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 Protein engineering can be performed by combinatorial techniques (directed 
evolution) and data-driven methods using machine-learning algorithms. The main 
characteristic of directed evolution (DE) is the application of an effective and efficient 
screen or selection on a diverse mutant library. As it is important to have a diverse mutant 
library for the success of DE, we compared the performance of DNA-shuffling and 
recombination PCR on fluorescent proteins using sequence information as well as 
statistical methods. We found that the diversity of the libraries DNA-shuffling and 
recombination PCR generates were dependent on type of skew primers used and sensitive 
to nucleotide identity levels between genes. DNA-shuffling and recombination PCR 
produced libraries with different crossover tendencies, suggesting that the two protocols 
could be used in combination to produce better libraries. Data-driven protein engineering 
uses sequence, structure and function data along with analyzed empirical activity 
information to guide library design. Boolean Learning Support Vector Machines 
(BLSVM) to identify interacting residues in fluorescent proteins and the gene templates 
were modified to preserve interactions post recombination. By site-directed mutagenesis, 
recombination and expression experiments, we validated that BLSVM can be used to 
identify interacting residues and increase the fraction of active proteins in the library. 
 As an extension to the above experiments, DE was applied on monomeric Red 
Fluorescent Proteins to improve its spectral characteristics and structure-guided protein 
engineering was performed on penicillin G acylase (PGA), an industrially relevant 





 With advancement in protein engineering, biocatalysts can be more heavily 
utilized for chemical reactions than previously thought possible. Protein engineering 
involves improving enzymes to feature superior specificity, faster kinetics, or stability at 
higher temperature relative to the native enzyme. Protein engineering has been 
successfully applied to modify to the properties of the biocatalyst so that it can perform 
satisfactorily in non-native conditions that are optimal for product formation, thereby 
improving the utility of biocatalysts for industrial reactions. Examples of successful 
protein engineering projects include fluorescent proteins, hydrolases, lipases, esterases, 
hydantoinases, lyases and dehydrogenases and halohydrin dehalogenase (1-5). 
1.1 Enzymes are optimized for regulation 
 Enzymes are usually not optimized for catalyzing the reactions chemists find 
important. Enzymes obtained from organisms have undergone billions of years of 
Darwinian selection to improve the survival chances of its hosts. Implicitly, selective 
advantage was applied to the enzymes for regulation of the metabolic pathways but not 
for maximal catalytic acceleration. Generally, enzymes are also evolved to exist 
transiently as the living cell is also in a constant state of metabolic flux and non-
thermodynamic equilibrium. Thus, enzymes are synthesized when required and are easily 
degraded when they have served their purpose are not naturally evolved to be stable over 
the long run which is a desired characteristic for industrial processes. 
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1.2 Advantages of using enzymes 
 Enzymes are suited to a variety of industrial applications that synthetic catalysts 
do not perform as well. Enzymes perform chemo-, regio-, diastereo- and enantio- 
selective chemistry very well (6). Chemoselectivity refers to the reaction of the enzyme 
with specific functional groups thereby reducing side reactions, which complicate 
purification of the products. Regio and diastereoselectivity refer to the ability of the 
enzymes to react on functional groups located on different part on the same substrate 
molecule. Finally, enantioselectivity exists in enzymes because they have plasticity to 
bind to the (R)-enantiomer transition state than (S)-enantiomer transition state or vice-
versa. Thus, a prochiral substrate can be reacted to an optically active one. Another two 
advantages of biocatalysts include catalyzing reactions under milder conditions than 
chemically synthesized catalysts are able to do and lastly, enzymes are environmentally 
friendly as they are biodegradable.  
1.3 Paradigm shift: Tune enzymes for optimal reaction conditions 
 There is a paradigm shift in protein engineering for the application of enzyme 
technology (7). Instead of using a sub-optimal reaction condition due to enzyme 
limitations for product formation, one can now optimize the reaction conditions for 
maximal product formation and engineer the enzyme to work well at such conditions. 
This is made possible by recent advances in molecular biology and protein knowledge. 
Improved enzyme variants can now be engineered to confer functional advantages to the 
enzymes by utilizing molecular biology techniques to mutate residues (8). Online protein 
databases and the plethora of publications on protein research facilitate identification of 
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key residues in proteins. Smart selection of residues for mutations, coupled with a good 
screening method (9) for the improved variant, can evolve proteins for the desired 
reaction conditions that maximize the product yield. 
1.4 General methods to engineer enzymes 
 There is no consensus about the best way to engineer novel enzymes. One method 
to improve the enzymes is to randomly generate a library of variants that are then 
screened by a high throughput assay. There are a variety of library generation protocols 
available, it is not clear however, which library protocols is optimal as there is no prior 
work that systematically compared library protocols to the same set of proteins. Another 
relatively new method to improve proteins is to make a directed library in which the key 
residues are chosen for mutations to a limited set of amino acids (10-12). The residues 
can be determined either by analysis of sequence-activity relationships or sometimes with 
insight gained from crystal structure analysis, i.e. the crystal structure data can be used to 
figure out which residues need to be mutated to accommodate the new substrates. The 
above considerations inspired research into library generation protocols, the use of a 
machine learning language to analyze library variants for interacting residue. Fluorescent 
proteins and penicllin G acylase were chosen as the model proteins used for this 
investigation as they are relatively well-characterized proteins that would serve as a good 
starting point for protein evolution experiments. One important thing to note to is that 
fluorescent proteins are not biocatalysts or enzymes but they have a fluorescence 
phenotype that can be easily measured, similar to enzymes that catalyzes a reaction in 
which its products can be measured by an assay method. 
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1.5 Contributions of this work 
 This dissertation documents the development and application of protein 
engineering techniques to improve two proteins, the monomeric Red Fluorescent Protein 
(mRFP), a useful bioimaging protein, and penicillin G acylase (PGA), an industrially 
useful enzyme for synthesis of -lactam antibiotics. The background chapter, Chapter 2, 
will develop a framework for understanding the various types of protein engineering 
strategies available. Protein engineering techniques such as rational design methods, 
directed evolution, and data-driven protein engineering methods are described in detail 
along with additional information on mRFP and PGA proteins that supplements the main 
content chapters on these proteins.  
 Chapter 3 describes the synthesis, cloning, expression, characterization and 
evolution experiments on the mRFP protein. This work reports the use of a DNA 
synthesis method involving the use of codon-optimized primers and two polymerase 
chain reactions (PCRs) to generate the mRFP gene. The mRFP gene is then cloned into 
vectors that is then transformed into E.coli cells and induced to overexpress the mRFP 
protein. Following purification, the mRFP protein is spectrophotometrically 
characterized. The mRFP gene is then subjected to mutagenesis experiments and a high-
through put fluorescence screening method is applied to pick out the improved variants. 
 The next contribution in Chapter 4 reports on the application of recombination 
protocols, DNA shuffling and recombination PCR, on mRFP and other fluorescent 
proteins. This crucial study sheds insight on the robustness of two recombination 
protocols, compared systematically on fluorescent proteins. Up to 350 sequences were 
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obtained for recombination scenarios with high and low DNA identity levels. Different 
templates were used for recombination to check for any correlation to number and type of 
crossover that can be obtained. Two significant revelations were found.  First, we found 
that the use of two-sided skew primers, designed for annealing to either the heads of 
maternal gene or the tails of paternal genes, for recombination reduces redundant chimera 
generation and secondly, while recombination PCR can work to a lower identity level 
than DNA shuffling, the technique has the potential to have similar tendencies like DNA 
shuffling to produce non-unique redundant sequences. The results from this investigation 
will be very useful to protein engineers who use recombination techniques as a method to 
produce their library. 
 Although recombination library generation protocols are useful to produce protein 
sequences randomly, a restricted and smarter library in which residues relevant for 
activity are selected and mutated could improve the chances of success for enzyme 
engineering efforts using minimal amount of work. A method of identifying interacting 
residues using a machine learning language, Boolean Learning and Support Vector 
Machines (BLSVM) on mRFP and DsRed proteins is detailed in Chapter 5. The mRFP 
genes and DsRed genes were shuffled and their proteins expressed. The activity of 
fluorescent proteins was recorded and linked to its sequence. BLSVM was then used to 
analyze the sequence-activity information to identify interacting residues. Site-directed 
mutants were then created to confirm the presence of interactions. The insight obtained 
from BLSVM is also used to engineer templates, which improve the number of active 
variants that is obtained from recombination experiments. 
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 To make use of the molecular biology skills and insight obtained from the initial 
experiments on an industrially relevant enzyme, the evolution of PGA towards altered 
substrate specificity was performed. Chapter 6 describes the analysis of 3-D crystal 
structures to select residues for mutations and the optimization of a high throughput assay 
for screening variants with substrate specificity change. An overlap extension PCR 
method was used to generate degenerate libraries, which were screened for using a 
Schiff-base assay that detects the hydrolysis product of antibiotics. Secondary assays 
involving the use of high performance liquid chromatography (HPLC) was also 
performed to confirm activities of screened variants. 
 Finally, conclusion and recommendations will be discussed in Chapter 7. This 
chapter will highlight the contributions of this work and suggest experiments for future 
investigations into data-driven protein engineering projects, point out another method to 
evolve an mRFP with brighter spectral emissions, propose intermediate substrates for 
PGA screening and explore other high throughput fluorimetric assays for PGA. 
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BACKGROUND: PROTEIN ENGINEERING METHODS 
2.1 Improving biocatalyst performance 
 The performance of enzymes as catalysts in reactions can be improved by 
changing the solvent, pH, substrates, temperature and by engineering the enzyme via 
alteration of the DNA sequence coding for the protein. The majority of enzymes are 
stable in aqueous media of mild pH (1). Activated substrates such as esters or amides can 
be used to achieve reasonable yields for kinetically controlled chemical reactions (2-5). 
The effects of ions on protein stability can be characterized by the Hofmeister series 
(6,7). In brief, some anions such as phosphates and sulphates are stabilizing 
(kosmotropes) while bromide and chloride destabilize (chaotropes) the proteins possibly 
due to hydration ion effects on the protein. Proteins are sensitive to the temperature as 
proteins unfold and eventually become inactivated when exposed to temperatures above 
its melting point (Tm) or below its cold denaturation temperature (Tc). The kinetic 
stability and thermal stability can be measured using a residual activity assay after heat 
deactivation (half-life, t1/2) or differential scanning calorimetry (melting temperature, Tm), 
respectively (8). Finally, modifying the amino acid sequences through mutagenesis can 
alter the properties of the enzyme or biocatalyst and improve its performance in non-
native conditions (9). This powerful method can tailor the proteins for the optimal 
reaction conditions. This section will discuss the various protein engineering methods 
that have been developed to date. 
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2.2 Concept of protein sequence landscape 
 
Figure 2.1  Protein fitness landscape. The xy-plane represents the sequence space while 
the z-axis shows the function of the biocatalyst. Enzymes are shown as colored ribbons 
and arrows represent mutational trajectories. The peaks and valleys illustrate the complex 
relationships between sequence and function of the enzyme. 
 The sequence and the activity of proteins can be visualized as a fitness landscape 
(10,11). If we plot the sequences of a protein in the two dimensional xy plane, the z-axis 
can represent the function of the biocatalyst. Figure 2.1 is a hypothetical plot of one such 
graph. The ribbons represent folded proteins and the arrows show hypothetical protein 
evolution pathways. The sequence-function or fitness landscape includes valleys that 
represent unfolded and deactivated proteins while the peaks show proteins with local 
optima activity. The protein engineering experiments described below traverse the 
protein landscape in search of a more optimal solution for the reaction at hand. In other 
words, protein engineers seek to find peaks in the fitness landscape. 
2.3 Protein engineering methods 
 Protein engineering methods can be divided into three groups - rational, 
combinatorial (directed evolution) and data-driven protein engineering. This section will 
detail the applications, successes, advantages and pitfalls of various protein engineering 
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methods. 
2.3.1 Rational Design 
 Rational design of proteins usually requires crystal structures and knowledge 
between the sequence-function as well as mechanism of the catalysis. This method 
involves knowing what residues to target and replace in the protein to obtained the 
desired effects. The application of rational design starts with the analysis of the crystal 
structure. Point mutations are then substituted into the protein via techniques such as site-
directed mutagenesis or overlap extension PCR. The mutants are then assayed for 
improved function. The procedure is low throughput and thus does not require a high 
through put screen. Rational design has been used successfully on fluorescent proteins to 
design calcium binding proteins (12), to transform amyloid-like fibrils to monomeric -
sheet proteins (13), to confer triose phosphate isomerase (TIM) activity on ribose binding 
proteins (RBP) (14), relaxing the nicotinamide cofactor requirement of phosphite 
dehydrogenase (15) and designing more stable proteins (16). 
 One good example to highlight the application of rational design method is the 
work performed on conferring TIM activity on ribose-binding proteins (14,16). TIM 
catalyzes the interconversion of dihydroxyacetone phosphate (DHAP) and 
glyceraldehyde 3-phosphate (GAP), constituting an important part of the Embden-
Meyerhof pathway (17). Dwyer et al. first tested if RBP can be redesigned to bind to 
DHAP and GAP. Stereochemical complement ligand-binding surfaces on RBP were 
identified using a modified dead-end elimination algorithm (DEE) (18,19) that take into 
account ligand docking and placement of amino side-chain rotamer libraries using van 
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der Waals, hydrogen bonding, solvation and electrostatic energy minimization 
considerations. The authors found four designs that bind to DHAP and GAP with 
micromolar affinities that were determined by coupled colorimetric enzyme assays. 
Subsequently, catalytic activity is introduced by introducing catalytically active residues 
into the receptor design process. This involves geometrically defining key interactions 
that contribute to binding (Figure 2.2), identification of positions where placement of  
catalytic residues and substrate (20) that simultaneously satisfies the geometric constrains 
and lastly, the complementary surface is generated around the placed substrate. Using the 











Figure 2.2  Geometric definition used by Dwyer et al for rational design of TIM activity 
in ribose binding protein. Geometric constraints were obtained in terms of bond lengths, 
angles and torsions for each residue relative to the enediolate. Figure adapted from (14). 
 Rational design efforts are limited by the availability of crystal structures and 
mechanistic knowledge. In 2007, there are currently 46,051 crystal structures with about 
10,000 – 20,000 unique sequences (based on BLASTclust, 30% - 95% sequence identity 
levels) available from the Protein Data Bank (21) that can be used (Figure 2.3). Although 
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there are large numbers of crystal structures in absolute terms, however, relatively 
speaking, it is small when compared to the diversity of species and number of genes 
present in each species. Thus, crystal structure data is not always available for the protein 
studied and not all proteins can also be easily crystallized. One alternative to using crystal 
structure is homology modeling whereby homologous can be used to make crystal 
structure for analysis purposes (22). Lastly, mechanistic knowledge of the protein of 
interest is not always accessible. In the above TIM example, mechanistic knowledge of 
the TIM isomerization was available. Implicitly, this helped in the selection of residues 
for substitutions and determination of the type of mutations desired for the rational design 
of TIM activity in RBP proteins. 
 
*data obtained from Protein Data Bank (21) 
Figure 2.3 Growth and total number of PDB structures over time.   
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2.3.2 Directed evolution 
 Directed evolution also known as molecular evolution involves the generation of 
library diversity randomly (> 10
6
 variants), which is then followed by a high throughput 
screening or selection method (23). One key advantage of directed evolution is the lack 
of requirement for crystal structure data and mechanistic insight. To start with, 
accessibility of the DNA information is required and a robust high throughput screen. 
Directed evolution has been used to improve activities and evolve new functionalities for 
proteins such as esterase, aspartate aminotransferase, biphenyl-dioxygenase, cytochrome 
P450, penicillin G amidases and monomeric red fluorescent proteins to name a few (9,24-
26). Such proteins can have complex sequence-structure relationships that cause rational 
methods to fail to work. This section discusses the library generation methods and the 
considerations of library screening.  
 Random library generation methods can be broadly divided into two types – 
random mutagenesis and recombination based methods. In short, one conventional 
random mutagenesis method known as error-prone PCR (ep-PCR) involves the use of 
manganese ions with skewed deoxyribonucleotides concentrations in the PCR reaction 
(27). The products resulting from the ep-PCR reaction are prone to erroneous 
substitution, thus, introducing point mutations into the gene. Another library generation 
method, recombination, combines the genes to produce chimera variants. In particular, 
DNA shuffling (28,29) consists of two steps. The genes are first fragmentized using 
enzymes such as DNAse I and an assembly PCR is done in which fragments of genes 
form the full length chimeras genes. An additional PCR is performed to amplify more 
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chimeras for cloning. 
 Library quality is important for success of directed evolution experiments (29). 
The quality of a library depends on its parental background, sequence and bias in 
sequence diversity. A library that has high percentage of parental templates and 
repetitions of non-unique sequences wastes screening efforts and resources. A biased 
library would limit the sequence-space search for improved variants. All random library 
generation protocols have inherent bia that can be controlled to some extent 
(recombination protocols are discussed in Chapter 4).  
 High throughput selection or screening assays are a pre-requisite for directed 
evolution experiments (30-32). In general, the selection or screens need to be robust so 
that it can be easily reproducible and give consistent results. Selection refers to genetic 
screening methods in which the cells expressing the protein variants either survives or 
dies depending on the ability of the protein to confer survival advantage to its host cells. 
Screening methods, on the other hand, involve assays that include color or fluorescence 







Table 2.1 Screening methods. 
Method Description References 






Fluorimetric Format: 96-well plates, agar plates, fluorescence 
activated cell sorter 
Uses: Activity, folding assays, binding 
















Ribosome display Format: Agar plates 









Format: 96-well plate possible 
Uses: Assays without known colorimetric or 
fluorimetric substrates 





 One prior work by Zhao and Arnold serves to illustrate the application of directed 
evolution to evolve thermal stability (41). Subtilisin E genes was subjected to ep-PCR 
and a recombination method called staggered extension process (StEP) (42). The screen 
consisted of subjecting the variants to a temperature challenge, which is then followed by 
a colorimetric assay utilizing succinyl-Ala-Ala-Pro-Phe-p-nitroanilide, improved variants 
with better thermo-stability were found. The best variant with eight mutations, had a half 
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–life that was 200 times more than the wild-type Toptimal and it is also more active than the 
wild-type enzyme. 
 Directed evolution is a useful method but is resource intensive. Tens of thousands 
of colonies need to be screened before having a good chance to converge at an acceptable 
solution. It is also not clear if directed evolution would work in all cases of enzyme 
evolution as enzymes could potentially have evolutionary limits. For example, Miller et 
al. applied directed evolution on -isopropylmalate dehydrogenase to switch its 
coenzyme specificity from nicotinamide adenine dinucleotide (NAD) to nicotinamide 
adenine dinucleotide phosphate (NADP) (43). They found evolutionary constrains on the 
variants they obtained as the mutants always had lower NADP affinity levels when 
compared to NAD.  
2.3.3 Data-driven protein engineering 
 Data-driven protein engineering combines bioinformatics, experimental data and 
computational tools together to evolve proteins in a smarter way, which minimizes 
experimental work to maximize the probability of obtaining improved variants. There are 
a couple of variations of data-driven protein engineering to date, but their central theme 
remains the same – all of them involves creating a targeted library that optimizes the 
chances of success. One recent review on data-driven protein engineering by Chaparro-
Riggers et al. (44) classifies the various types of data-driven protein engineering into the 
following groups listed as follows: structure-based, homology-based, computation-based 
and combination-based methods. To be consistent with literature, similar terminology and 
groupings were used in the following paragraphs to illustrate the different types of data-
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driven protein engineering developed. 
2.3.3.1 Structure- and homology- based engineering 
 Structure-based engineering methods require three-dimensional crystal structures 
from which intelligent guesses are made to choose the residues for mutation. Morley and 
Kazlauskas showed that mutations near the active sites would be more useful than 
random mutations to generate variants with improved enantioselectivity and substrate 
specificity (45). Figure 2.4 shows the change in activation free energy as a result of the 
mutations. Evidently, most of the improved variants are centered close to the active sites. 
These findings suggest that for experiments to change enantioselectivity and substrate 
specificity, the use of a crystal three dimensional structure coupled with a targeted 
random mutagenesis method or site-saturation mutagenesis method is a better approach 
to evolve the protein of interest.  
  
Figure 2.4  (a) Change in free energy for enantioselectivity and (b) Change in free energy 
for substrate specificity. Figure was adapted from (45).  
 Structure-based engineering can be combined with homology alignment data to 
choose residues for mutation. In addition to using the crystal data information, the amino-
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acids sequence alignment can be utilized to determine residues for mutations. One such 
method is the consensus approach applied on pencillin G acylase. Polizzi et al (46) 
sought to improve the thermo-stability of penicillin G acylase. They used sequence 
alignment data on seven variants of penicillin G acylases and reduced the number of 
mutations from 109 to 21 positions by analyzing the crystal structure data and eliminating 
mutations close to the active site. They obtained 10 variants with improved thermo-
stability without affecting activity significantly. 
 In some cases, structure-based techniques can be coupled with computational 
methods and homology data to generate better libraries (47-49). The computational 
methods for these approaches to identify interacting and important residues include 
considerations listed as follows: Volumetric, polarity, electrostatics, distances from other 
amino acids. The libraries can then be designed to minimize incompatibilities. For 
example, Mena et al. evolved a brighter blue fluorescent protein with improved photo-
stability and relative quantum yield by first analyzing the crystal structure data and then 
used a computational algorithm that maximizes preservation of activity to limit size of 
the library generated which were subsequently screened fluorimetrically. 
2.3.3.2 Computational-, Algorithm- and scouting-based engineering 
 Scouting-based methods can be used to design smart libraries to accelerate 
convergence towards improved proteins. These methods consist of using sequence-
activity data obtained from either parallel experiments or designed single-point mutation 
experiments – the goal of which is to obtain an initial sequence-activity data on the 
proteins. Following that, computational analysis involving machine learning algorithms 
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and or linear regression can identify important activity residues and non-linear 
interactions. Site-saturated libraries can then be designed around these residues, thus, 
speeding up protein engineering efforts. 
 
Figure 2.5 Application of ProSAR algorithm. Sequence-activity data is obtained which is 
then analyzed using ProSAR. The cycle can be iterated to obtained more data until 
satisfactorily improved variants are obtained. Figure adapted from (50). 
 One good example to highlight the application of such an approach is the work 
done by Fox et. al on evolving halohydrin dehydrogenase for the production of ethyl (R)- 
4-cyano-3-hydroxybutyrate, a starting material for producing the cholesterol lowering 
drug atorvastatin (Lipitor). Figure 2.5 illustrates the methodology of applying the linear 
regression algorithm, protein sequence activity relationship algorithm (ProSAR). DNA 
shuffling, random mutagenesis and rational design methods were first used to generate 
the libraries that were assayed then analyzed using a ProSAR. ProSAR is a statistically 
based learning method that can infer mutational effects contribution to protein function. 
Figure 2.6 shows an example of the ProSAR output. The combined method yielded an 
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improved halohydrin dehydrogenase with 4000-fold activity relative to wild-type. 
 
Figure 2.6  Output from ProSAR analysis. The y-axis represents the effects of mutation 
that is plotted against the type of mutation on the x-axis. The black colored bar represents 
results taken initially and the clear bars are results taken with thermal challenge. Data 
obtained from (50).  
 Although there are a number of different protein engineering approaches, it 
remains contentious if any particular method is superior. As mentioned above, rational 
design, directed evolution and data-driven methods all have successful examples of 
creating improved protein variants. All of them need a library generation method and a 
good robust screen. The choice of the protein engineering approach or approaches will 
likely be dependent on the type of protein, the amount of literature on the protein, the 
type of assays that can be used and the resources available to the protein engineers. To 
expand understanding of library generation utility on proteins with different homology 
levels and to validate the applicability of a machine learning language, Boolean Learning 
Support Vector Machines (BLSVM) for use in guiding directed evolution, this 
dissertation will report on the performance of recombination and the results of using 
BLSVM on fluorescent proteins. As an extension, we also looked into evolving 
monomeric Red Fluorescent Proteins using directed evolution and a structure-guided 
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CLONING AND EVOLVING MRFP  
3.1 Introduction 
 Fluorescent proteins are an important class of proteins for bio-imaging studies, 
expression monitoring, protein-interaction studies and other functions such as calcium 
ion biosensors and photo-sensitizers (1-8). Most fluorescent proteins consist of a -can 
structure that protects the chromophore from quenching by oxygen and keeps the angle of 
the chromophore moiety at slightly less than 180° (9,10). As a consequence, fluorescent 
proteins can also serve as folding reporters since folding is essential for fluorescence to 
occur. The utility of the fluorescent proteins depend on their photophysical 
characteristics. Spectral considerations suggest that red fluorescent proteins have better 
signal to noise ratios than green fluorescent proteins (8). In particular, the monomeric 
Red Fluorescent Protein (mRFP) is a useful tag-fusion fluorescent protein as it is a 
monomeric protein with higher signal to noise ratio (Figure 3.1) than Green Fluorescent 
Proteins (GFPs). However, it suffers from low relative quantum yield of 0.25 and a more 
red-shifted mRFP from a current maximum at 610 nm is desirable to reduce background 
noise in the presence of red blood cells. This chapter describes protein engineering effort 




Figure 3.1  Absorption spectral of water, oxygenated haemoglobin and haemoglobin. 
Adapted from reference (8). 
 
3.1.1 Fluorescent proteins origin 
 Most of the known fluorescent proteins are derived from organisms living in the 
ocean. To date, fluorescent proteins have been found and cloned from sea-dwelling 
organisms such as Aequorea victoria jellyfish (11) and corals such as Anthozoa (12), 
Pectinidae (13) and Discosoma species (14). The GFP protein from Aequorea victoria 
jellyfish was the first fluorescent protein isolated. In 1979, Shimomura deduced the 
structure of the GFP (15,16), which eventually led to a landmark paper on expression of 
GFP by Chalfie et al in 1994 (17). Since then, other fluorescent protein variants were 
discovered and engineered, they became, along with GFP, commonly used tools in 
molecular biology, medicine, and cell biology (9). However, despite many years of 
research, the function of these fluorescent proteins in these sea-dwelling organisms 




3.1.2 Properties of fluorescent proteins 
Table 3.1  Lists of selected fluorescent proteins and their applications. 
Name Use(s) References 
DsRed and GFPs, mGFP, mRFP, 
mCherry, mPlum, mStrawberry, 
mBanana 
Bioimaging, protein-protein 
interactions, reporter, screening 
for folded proteins 
(19) 
CFP and YFP, CFP and YFP FRET, detection of 
conformational changes 
(18) 





 detections (24) 
EGFP, pHluourin  Ratiomeric detection of pH (25,26) 
HyPer Hydrogen Peroxide detection (27) 
KillerRed Photosensitizer* (1) 
*Photosensitizer refers to a compound that produces reactive oxygen species upon light 
excitation 
 
 The utility of fluorescent proteins for various applications is dependent on its 
aggregation tendency, quantum yield, extinction coefficient, photostability, excitation and 
emission spectral range as well as sensitivity to environmental effects such as pH (18,19). 
Some fluorescent proteins have the tendency to associate, forming dimers and/or 
tetramers and dimers, which can prove fatal to cells if it induces aggregation of proteins. 
The emission intensity of the fluorescent protein is a function of the aggregative state of 
the proteins, the quantum yield and the extinction coefficient (20). The photostability of 
the fluorescent protein is a measure of the ability of the fluorescent protein to withstand 
photobleaching due to destruction of the fluorophore after repeated rounds of excitation 
and emission (19). The excitation and emissions spectral range of the fluorescent species 
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will determine its application for use in combination with other fluorescent probes for 
protein-protein interactions investigations and simultaneous tracking of movement of 
different proteins and cells simultaneously. Some fluorescent proteins are sensitive to pH 
and thus can be used for pH detection. Examples include pHluorine and EGFP which 
have been used for measurement of pH in vivo and detection of hydrolytic activity (see 
Table 3.1).  
3.1.3 mRFP protein: a useful monomeric red fluorescent protein 
 The monomeric red fluorescent protein (mRFP) protein is a more useful 
fluorescent protein than GFPs. The mRFP protein experiences less signal to background 
noise than GFPs which area frequently used in labs, which are frequently used in labs. 
The use of GFPs in mammalian systems is disadvantaged as its emissions range from 540 
nm to 590 nm which is absorbed by red blood cells (8). Another advantage of mRFP is its 
monomericity that confers reduced tendency to aggregate when expressed as a tag-fusion 
protein (28). 
 The mRFP was engineered from DsRed through directed evolution combined 
with rational design. Campbell et al. engineered the mRFP from the tetrameric DsRed 
protein by using crystal structures of DsRed protein and introducing arginine mutations 
into interacting residues I125, T147, H162 and F224 to disrupt the sub-units (28). The 
fluorescence of the mRFP was then rescued by directed evolution, a process that involves 
the generation of a large number of mutants using random mutagenesis which is then 
screened using a cooled charged coupled camera with 560 nm excitation and 610 nm 
bandpass filters. In total, 33 mutations were introduced into DsRed protein. Of these 
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mutations, 16 mutations were reducing aggregation while 17 mutations were beneficial 
for brightness and maturation. 
3.1.4 Improved mRFP with red-shifted emissions and better relative quantum yield 
desired 
 The mRFP protein was one of the few rapidly maturing (< 1hr), red-shifted 
monomeric fluorescent that can be useful for bioimaging and labeling experiments. 
However, the mRFP was not red-shifted enough (607 nm emissions) and suffers from a 
low relative quantum yield (0.26) in comparison to GFPs with relative quantum yields of 
0.79 (4). Weissleder (8) suggested that fluorescent probes should ideally have emissions 
in the near-infrared red region, from ~650 nm to ~850 nm range (Figure 3.1). Most 
fluorescent probes currently have emissions that suffer from high signal to background 
noise as a result of absorbance by red blood cells. Thus, to make a more useful mRFP, we 
decided to engineer mRFP through directed evolution.  
3.1.5 Scope of work 
 The engineering of mRFP towards a more red-shifted wavelength using directed 
evolution will be described in this chapter. The mRFP library was generated using error-
prone PCR (ep-PCR) and the library was screened using fluorescence activated cell 
sorter. The variants obtained were purified using metal-chelation chromatography and the 
relative quantum yields were measured.  
3.2 Materials & Methods 
3.2.1 Materials 
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 Most of the enzymes were bought from New England Biolabs (Beverly, MA). 
The Pfu and Taq polymerase were purchased from Stratagene (La, Jolla, California). 
XL1-Red E. coli cells were bought from Stratagene(La, Jolla, California). Tetracycline 
and chloroamphenicol were purchased from Sigma (St. Louis, Missouri). All 
oligonucleotides were ordered from MWG-Biotech (High Point, North Carolina). The 
inducer, anhydrotetracycline (ATC) was made by dissolving 250 mg/l of tetracycline in 
water and adjusted to pH 3 and autoclaving for 45 mins. Mass spectrometry confirmed 
that anhyrotetracyline was obtained (See supplement). 
3.2.2 Synthesizing codon-optimized mRFP protein 
 The amino acid sequence of mRFP was obtained from NCBI and E. coli-codon 
optimized primers (supplement 3.7.1) were designed using DNAworks (29) and 
synthesized. The mRFP gene was obtained via two PCR reactions, one to assemble the 
codon optimized primers, and the second to amplify the full length product. The gene was 
amplified using primers with Esp3I (italicized) restriction sites (5’ -TAC GTC TCG TCG 
ACA TGG CGT CTT CTG AAG ACG TTA TCA AAG AAT TCA TGC GT – 3’ and 5’ 
– TAC GTC TCT GGC CTA TTA CGC ACC GGT AGA GTG ACG ACC TTC - 3’) and 
digested with Esp3I enzyme and ligated using T4 DNA ligase into SalI and NotI digested 
pPROTet vector. Sequencing, expression and characterization consistent with the 





3.2.3 Creating variants 
 The error-prone PCR (ep-PCR) protocol from Zhao et al was followed. The 
following solutions were made. 10X Mutagenic buffer consisting of 70 mM MgCl2, 500 
mM KCl, 100 mM Tris and 0.1% (wt/vol) gelatin was used. A solution of 5 mM MnCl2 
and a dNTP mix consisting of 2 mM dGTP, dATP and 10 mM of dCTP and dTTP. The 
final PCR mix consists of 10 μl of 10X mutagenic buffer, 30~50 pmol of each primer, 2 
fmol of template DNA and an amount of distilled H2O to bring the final volume to 96 μl. 
3 μl of 5 mM MnCl2 is then added to the PCR solution which is mixed either by pipetting 
or flicking. 1 μl of Taq polymerase is added (~5 U/l). The PCR mixture is cycled as 
follows: 14 cycles of 30 s at 94°C, 30s at 50°C, and 30 s at 72°C. The products were gel 
purified and digested with the SalI and NotI enzymes and cloned into same restriction 
sites in pPROTeT.E133 vector. 
 A mutator E. coli cell strain, XL1-Red was also used to generate error-prone 
variants according to the product manual. (Catalog # 200129, Revision #064003, 
Stratagene). Briefly, the mRFP template in pPROpTeT plasmid was transformed into 
XL1-Red cells. Approximately 200 colonies were picked and grown in ~5-10 ml of LB 
broth overnight at 37°C. The colonies were then minipreped and retransformed into XL1-
blue cells, which were then picked for screening. 
3.2.4 Expression and normalization of cell expression 
 Freshly transformed cells were picked from LB choramphenicol agar plates and 
grown in 96-well plates. Each well had 200 μl of LB chloramphenicol in 96-well plates 
overnight at 37°C and 150 rpm till stationary phase. Each plate had a perimeter of non-
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inoculated wells to mediate evaporation and mRFP positive control cells.  Following that, 
20 μl of culture was then transferred to another 96-well plate with 180 μl of LB 
chloramphenicol and inducer, ACT in each well. The final concentrations of ACT and 
CM in each well were 1 μg/ml and 20 μg/ml respectively. The cultures were then 
incubated at 30°C at 150 rpm until readings were taken ~30 hrs later using the Fluostar 
Galaxy fluorimeter with excitation filters and emission filters set at 540 nm and 590 nm 
respectively.  
3.2.5 Batch purification of His-Tagged mRFP 
 In general, protocols from PROTet
TM
 6xHN Bacterial Expression System User 
Manual and BD TALON
TM
 Metal Affinity User Manual were followed. Freshly 
transformed colonies were picked and grown overnight in 5 ml LB CM (20 μg/ml) at 
37°C and 150 rpm. The overnight culture was transferred to fresh LB CM media and 
diluted 1:50 times the next day. The culture was incubated at 37°C for ~4 hrs, when the 
culture reached an OD600 of 0.5, it was induced by adding ACT to a final concentration of 
1 μg/ml. After 24hrs, the culture was harvested by centrifugation at 1000-3000 x g for 15 
min at 4°C. The cell pellet was resuspended by vortexing in 5 ml of 1X Extraction/Wash 
Buffer (4°C, 50mM NaPO4, 300mM NaCl, pH 7) per 500 ml of culture. The cell extract 
was sonicated on ice for 6 x 30 s. The cell extract was centrifuged at 10,000-12,000 x g 
for 20 min at 4°C. The supernatant was then transferred over to a clean tube. About 1 to 
5ml of the re-equilibrated BD TALON cobalt resin was added to bind the his-tagged 
proteins. After mixing the resin with the clarified cell extract for 20 min, the suspension 
was spun down at 700 x g at 4°C for 5 mins. The supernatant was removed and the resin 
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washed twice with 10-20 bed volumes of 1X Extraction/Wash buffer. Each wash consists 
of 10 min on the platform shaker and centrifugation of the suspension at 700 x g at 4°C 
for 5 mins. 5 bed volumes of the elution buffer (50 mM NaPO4, 300mM NaCl, 150mM 
imidazole, pH 7) were then added to the column to obtain the purified proteins. The 
eluted proteins were dialyzed (30,000 MWCO) in a 1 L solution of 1 x Extraction/Wash 
buffer overnight at 4°C. Protein gels confirmed that > 95% pure mRFP was obtained (see 
supplement). 
3.2.6 Measuring relative quantum yield 
 The emission spectral of equally absorbing species of Rhodamine 101 and 
fluorescent protein were taken using a Photon technology fluorimeter (Model 814, PTI 
international, Birmingham, New Jersey). The relative areas under the emissions curve 
were determined for mRFP to Rh101 – this gave the relative quantum yield. 
3.2.7 Fluorescence activated cell sorting (FACs) of variants 
 Freshly transformed cells were grown overnight and induced with ACT (1 μg/ml 
final concentration) after 18 hrs. The cultures were spun down and resuspended in sterile 
phosphate buffer saline, pH 7.5 and placed on ice. FACs sorting was done using a BD 
immunocytometry system (Model: FACSVantage SE DIVA, San Jose, California) in 
combination with the excitation/emission filters. APC-A: 647 nm/675 nm, FL-6: 488 nm/ 
660 nm and PerCp-Cy5-5: 488 nm/ 630 nm. Colonies with the highest intensity were 
sorted for. 1 ml of sterile PBS were added to the sorted variants. The variants were then 
plated on LB CM plates and incubated at 30°C overnight. 
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3.3 Results 
3.3.1 Characterization of cloned mRFP 
3.3.1.1 Synthesis and sequencing of the mRFP gene 
 The full-length gene of mRFP protein was obtained via gene synthesis. This 
involved two PCR steps, of which the first PCR involved gene assembly and the 
secondary PCR amplified full-length product. The DNA electrophoresis gel pictures for 
both the PCRs are shown below in Figure 3.2. Gel A shows the DNA gel electrophoresis 
of the primary PCR in which oligonucleotides were assembled together to form the full-
length mRFP gene. It can be observed that lanes four, five and six show a PCR band the 
size of ~700 bp.  Gel B shows the secondary PCR of the primary PCR bands. PCR bands 
were around the size of 700 bp which is the expected gel band that should be obtained 
from the mRFP full-length gene. 
  
Figure 3.2  DNA gel electrophoresis of primary PCR product and secondary PCR 
product. Lanes: A1 and B1: 100 bp Perfect DNA Ladder. Lanes B6 and B10: 0.05 – 10 
kbp Perfect DNA ladder. Lanes A2 to A7: primary PCR with various primer 
concentrations. Lanes B2 to B5: secondary PCR from primary PCR as a template. Red 
arrows mark expected gene size of 678 bps. 
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 The mRFP gene was cloned into cloning vector, pDrive plasmid, and sent for 
sequencing to confirm that we obtained the mRFP full-length gene. Figure 3.3 shows the 
obtained DNA sequence of the mRFP gene, which matches the expected sequence, and 
Table 3.2 shows the expected amino acid sequence of the recombinant mRFP. The 
sequenced verified full-length mRFP gene is then cloned into pPROTet.E133 plasmid, 
transformed into DH5 pro E. coli cells, induced using anhydrotetracycline to express the 
mRFP protein. Evidently, we were successful in synthesizing the mRFP gene since a 
PCR band around 600 to 700 bp was obtained and the expressed protein is fluorescent in 
vivo (see Figure 3.4). 
 
Figure 3.3  DNA sequence of the synthesized mRFP gene.
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Table 3.2  Comparison of amino-acid sequence of mRFP from NCBI and the histidine 
tagged mRFP protein sequence expressed from the recombinant mRFP pPROTeT.E133 
plasmid.  








DGALKGE IKMRLKLKDG GHYDAEVKTTYMAKKPVQLPGAYKTDIKLD 
ITSHNEDYTI VEQYERAEGR HSTGA 













Figure 3.4  Figure showing the expressed recombinant N-terminal His-Tagged mRFP 
expressed DH5apro cells using pPropTET.E133 plasmid. 
 
 The expression of mRFP was monitored over a period of 70 hours. The 
recombinant DH5 pro cells was first grown overnight and then transferred in 1:200 ratio 
to fresh LB containing chloramphenicol and induced with ACT when the O.D of cells 
reach 0.5. Figure 3.5 shows the expression curve for mRFP recombinant cells. It can be 
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determined that the optimal expression time is approximately 24 hours and the optimal 
concentration of ACT to induce expression is 1 μg/ml. 
 





































Figure 3.5 Induction with autoclaved tetracycline (ACT) concentrations ranging from 100 
to 50,000 ng/ml and 100 ng/ml of anhydrotetracycline (ATC). The optimal inducer 
concentration was determined to be 1000 ng/ml for ACT. 
 
 Purified mRFP was obtained from metal-chelation chromatography of a 1 L batch 
culture. From a protein gel picture (Figure 3.6), we could determine that up to 20% of 
overall protein production was mRFP protein. 95% purity of mRFP protein could be 
obtained from metal-chelation purification. We managed to obtain 30 mg purified mRFP 






   Lanes  1    2    3     4      5 
 
Figure 3.6 Protein gel of mRFP. 1 & 5: Fermentas unstained and Prosieve unstained 
ladders. 2: Purified mRFP (arrow), 3: mRFP cell lysate induced & 4: Cell lysate 
uninduced. 
 
3.3.1.2 Spectroscopic scan and measurement of relative quantum yield 
 The absorption spectrum, emission spectrum, and relative quantum yield of mRFP 
were found to be consistent with literature (28). The absorption and emissions spectral 
are shown in Figure 3.7. The mRFP protein has an excitation maximum at 584 nm and an 
emission maximum at 607 nm. The emission spectral (Figure 3.8) of equally absorbing 
species of mRFP and rhodoamine 101 were integrated and the ratio of the integration was 
calculated to obtain the relative quantum yield of mRFP to rhodamine 101. The relative 























Figure 3.8  Emissions curve of rhodamine 101 (ethanol solution) and 6x His-Tagged 
mRFP (Na2HPO4/NaH2PO4 buffer, pH 7.0). The relative quantum yield of mRFP was 
calculated to be 0.25.  
 
3.3.2 Generation of mutants of mRFP using error-prone PCR and XL1-Red 
mutator cells 
 Error-prone PCR was used to create variants of mRFP. In error-prone PCR, one 
can vary the rate of mutation by adjusting the concentration of MnCl2 or starting template 
concentration in the PCR mix. The increase of MnCl2 concentration should in theory also 
increase the rate of mutation. Decreasing the template concentration used for ep-PCR will 
also increase the rate of mutation as there will be less wild-type template relative to error-
prone amplified templates for PCR. The ep-PCR amplified templates serve as new 
templates for further amplification, thereby increasing the rate of mutation.  
 To estimate the mutation frequency, we expressed 96 samples of mRFP variants 
along with the wild-type mRFP and sequenced ep-PCR variants that were generated 
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using various MnCl2 concentrations. A convenient means to estimate the rate of mutation 
is to use activity screens (30). An increase of the rate of mutation correlates with an 
increase of deactivation due to the accumulation of deleterious mutations. As it can be 
observed in Figure 3.9, an increase in the MnCl2 concentration corresponds to a decrease 
of activity as the number of variants that are active (> 0.2 normalized fluorescence). We 
also sequenced ep-PCR variants to confirm the effect of varying MnCl2 on rate of 
mutation (Table 3.3).  
 







Table 3.3  Sequence-activity data on selected ep-PCR variants. ep-PCR variants produced 


















Amino Acid Substitutions 
60 25 B03 1.18 1 1 0.147 K184N 
  25 C01 1.2 0 0 0.000 - 
  25 C04 1.21 1 0 0.147 - 
  25 E01 1.24 0 0 0.000 - 
 25 H10 0.07 6 5 0.885 
S3F, E4G, D5G, I73 
(silent), G23R 
  25 H01 1.11 3 2 0.442 T201S, N205K 
200 25 F01 1.06 0 0 0.000 - 
  25 B05 0.06 5 5 0.737 
K122 Stop, M149V. 
D205N, E210Stop, R214S 
  25 E05 1.126 1 0 0.147 - 
  25 C12 0.98 0 0 0.000 - 
 25 E01 0.15 4 4 0.590 
D80G, V186D, N205K, 
D207E 
  25 C05 0.99 0 0 0.000 - 
  25 G07 1.12 1 1 0.147 - 
   
 We also transformed the ep-PCR plasmids and WT mRFP plasmids into XL1-Red 
mutator cells to generate variants. XL1-Red mutator cells have a deficient DNA 
replication system that introduces mutations in the plasmids. Thus, we effectively 
performed two rounds of mutations by using the ep-PCR variants as starting point and 
one round of ep-PCR by using WT plasmids as the template for XL1-Red cells, 
respectively. The variants were also screened using FACs.  
3.3.3 Screening of mRFP using Fluorescence Activated Cell sorter (FACs)  
 The mRFP variants with the highest fluorescent intensities at the red-shifted 
wavelength were screened for using FACs. Figure 3.10 shows the fluorescence intensity 
(axis plotted in logarithmic scale) of the point mutation variants. We can observe that the 
point mutations variants have more diverse (more spread out fluorescence population) 
fluorescence intensity (panels A, B, D in Figure 3.10) than the WT mRFP control cells 
(panel C). Gates P2 and P3 were used to select the desired colonies that we want. The 
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FACs sorted variants obtained from P3 are grown overnight and 60 fluorescent variants 
are randomly picked and expressed. The top variants were his-tagged purified and 




Figure 3.10  FACs selection on WT XL1-red cells (A:top left), round 2 point mutation 
variants (B: top right), WT mRFP control cells (C: bottom left) and 200 μM ep-PCR cells 
(D: lower right). APC-A and FL6-A are excitation and emissions filter settings. APC-A: 
excitation 647 nm, emission 675 nm. FL6-A excitation, 488 nm, emission 660 nm. P2 






Figure 3.11 Secondary screen on mRFP variants using 96-well plate fluorimeter.  A) 
Normalized fluorescence of FACs sorted mRFP variants generated using different 
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concentrations of MnCl2. The legend lists various concentrations of MnCl2 used to 
generate the variants. B) Normalized activity assay on FACs sorted variants generated 
using XL1-Red mutator cells. S4 used wild-type mRFP gene as a source while S5 
experiments used mRFP mutant templates from 150 mM MnCl2 ep-PCR experiments as a 
source. All readings were normalized to mRFP WT control cells.  
3.3.4 Characterization of top variants using Fluorimeter 
 The top variants obtained from the secondary screen were expressed and purified 
using metal-chelation chromatography methods (Table 3.4). The relative quantum yields 
for the purified variants were determined and it ranged from 0.25 to 0.27. The maxima of 
the emissions wavelength ranged from 602 nm to 609 nm. 
Table 3. 4 Characterized top variants from secondary screening.  
Sample ID Ex Max (nm) Em Max (nm) Rel  Q. Y. REMARKS
WT - B1 581 606 0.26 Tris pH 8.5 buffer
WT - B2 581 606 0.26 PHOS, NaCl buffer
S1B10 581 606 0.27
K138R, S222L, T223R, G224N, A225R, 226P, 
227L, 228N
S2G07 583 607 0.27 E160D
S2B11 583 606 0.26 K47I, possible 8T (DNA)
S2C10 582 606 0.25 M141V
S4E03 582 609 0.26 Native
S4B05 582 604 NC Native, S4-2
S4C04 580 605 NC Native, S4-1
S4D02 579 602 NC Native, S4-3
S4B06 582 608 0.26 Native
S5B02 577 602 NC R36R, CGT to CGC, S5-2
S5B05 584 608 0.26 R36R, CGT to CGC, S5-1
S5C02 582 607 NC R36R, CGT to CGC, S5-3
S5D10 583 607 NC E30G,  V96V GTT to GTA
S5C06 580 604 NC Native  
3.4 Discussion 
3.4.1 The mRFP gene 
 We managed to successfully synthesize, clone the mRFP gene, and express and 
purify mRFP itself. From sequencing information, we were able to verify that the correct 
 48 
genes were synthesized using the procedures described by Hoover et al. (29) The 
procedures were, in general, straightforward to apply involving two PCRs steps. The first 
step involves gene reassembly and the second amplification of the assembled genes. The 
expressed mRFP proteins had similar absorption and emission spectral when compared to 
literature (28). We managed to over-express mRFP up to 20% of protein expression in 
E.coli cells and obtained 30mg of purified mRFP from an estimated 100 mg of mRFP per 
l L batch culture. We determined that metal-chelation chromatography is an efficient 
method to purify histidine-tagged mRFP proteins. 
3.4.2 Library diversity generated by ep-PCR 
 The results from sequencing (Table 3.3) indicate that we successfully obtained a 
diverse set of sequences but parental background was also obtained. Typical ep-PCR 
efforts using varying concentrations of MnCl2 in the range of 60 μM to 200 μM to 
change the rate of mutations (31) report 0.11 to 2% mutation frequencies (1 to 20 
nucleotides per 1kb). In comparison, we obtained mutation frequencies of 0.15% to 
0.89% for mRFP gene whenever variants were generated. We also obtained a 50% 
background of WT variants – this probably arose from a small gene length (678 bp), 
which reduces the efficiency of ep-PCR due to a lower probability of mismatching 
complimentary base-pairing. The presence of background was probably not due to the 
presence of WT mRFP plasmids that contaminate the PCRs and transformation as the gel 




3.4.3 Two rounds of evolution and ep-PCR are insufficient to obtain improved 
variants 
 The mRFP is a plastic protein as it is found to be very tolerant to single point 
mutations and two rounds of directed evolution is insufficient to engineer an improved 
red-shifted variant. In our directed evolution experiments, we randomly mutated the 
mRFP gene using library generation protocols such error-prone PCR and E. coli 
mutagenic strain XL1-Red. We did not find improved variants after subjecting the library 
to FACs screening. Two publications (32,33) on the directed evolution of mRFP from 
Roger Tsien’s lab substantiate our view that red shifting the mRFP through directed 
evolution using ep-PCR to generate libraries is likely to be an unrealistic goal. 
 We found mRFP to be a protein of high plasticity as it can tolerate a number of 
amino acids substitutions and still retain its native characteristics. We have applied error-
prone-PCR on mRFP, generated a library using XL1-Red E. coli mutator strain and 
screened the variants by fluorescence activated cell-sorting (Figure 3.10). We expressed, 
purified and characterized the variants showing the highest intensity. Of the screened 
variants (Table 3.4), we did not find an improved variant suggesting that more mutations 
were probably required for evolving a red-shifted variant of mRFP. 
 Recently, Wang et al. showed the evolution of mPlum (32), a more red-shifted 
monomeric red fluorescent protein from mRFP by 23 rounds of somatic hypermutation. 
Somatic hypermutation (SHM) utilizes activation induced cytidine deaminase and error-
prone DNA repair to introduce point mutations into the genes located at the V regions of 
Ig locus. Wang et. al. cloned the mRFP gene into the V regions and performed 29 rounds 
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of SHM with FACs screening. The effort yielded mPlum, a monomeric variant of mRFP 
that has an emissions maximum at 649 nm, 42 nm more red-shifted than mRFP. The 
authors pointed out that conventional random mutagenesis method could not generate 
shifted mRFP variants of more than 623 nm. Seven mutations were introduced into 
mRFP to change it to mPlum and a much larger sequence space was searched. 
 Shaner et al. (33) reported on the evolution of improved monomeric fluorescent 
proteins in which they added four amino acids to the N-terminal and seven amino acids 
of GFP to the C-terminus of mRFP prior to applying directed evolution to the protein. 
They evolved a fluorescent protein, mCherry, whose emissions is 3 nm more red-shifted 
than mRFP.  
 The above mentioned research findings substantiate our view that two rounds of 
evolution is insufficient to search for an improved red-shifted variant of mRFP and that 
conventional directed evolution methods utilizing ep-PCR as a method to generate 
variants is not optimal. 
3.5 Conclusion 
 The mRFP gene was successfully synthesized, cloned and expressed. 
Subsequently, the analysis of the directed evolution efforts of the mRFP gene combined 
with recent work from other groups suggest to us that utilization of non-conventional 
library generation techniques and extensive mutagenesis were required to yield slightly 
red-shifted mRFP proteins – mPlum and mCherry.  
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3.7.1 E. coli expression optimized primers used for the reassembly of mRFP gene  
no. Primer Sequences 5’-3’ 
1 ATGGCGTCTTCTGAAGACGTTATCAAAGAATTCATGCGTTTCAAAGT 
2 TCGTATGGAAGGTTCTGTTAACGGTCACGAATTCGAAATCGAAGGTG 
3 AAGGTGAAGGTCGTCCGTACGAAGGTACCCAGACCGCGAAACTG   
4 AAAGTTACCAAAGGTGGTCCGCTGCCGTTCGCGTGGGAC  
5 ATCCTGTCTCCGCAGTTCCAGTACGGTTCTAAAGCGTACGTTAAACACCCGG   
6 CGGACATCCCGGACTACCTGAAACTGTCTTTCCCGGAAGGT   
7 TTCAAATGGGAACGTGTTATGAACTTCGAAGACGGTGGTGTTGTTA   
8 CCGTTACCCAGGACTCTTCTCTGCAGGACGGTGAATTCATCTACAA  
9 AGTTAAACTGCGTGGTACCAACTTCCCGTCTGACGGTCCGG   
10 TTATGCAGAAAAAAACCATGGGTTGGGAAGCGTCTACCGAACGTAT  
11 GTACCCGGAAGACGGTGCGCTGAAAGGTGAAATCAAAATGCG  
12 TCTGAAACTGAAAGACGGTGGTCACTACGACGCGGAAGTTAAAACC  
13 ACCTACATGGCGAAAAAACCGGTTCAGCTGCCGGGTGCG  
14 TACAAAACCGACATCAAACTGGACATCACCTCTCACAACGAAGACTACACCA  
15 TCGTTGAACAGTACGAACGTGCGGAAGGTCGTCACTCTACCGGTGCG   
16 TTACGCACCGGTAGAGTGACGACCTTC   
17 CGCACGTTCGTACTGTTCAACGATGGTGTAGTCTTCGTTGTGAGAGGTGAT 
18 GTCCAGTTTGATGTCGGTTTTGTACGCACCCGGCAGCTGAA   
19 CCGGTTTTTTCGCCATGTAGGTGGTTTTAACTTCCGCGTCGTAGT  
20 GACCACCGTCTTTCAGTTTCAGACGCATTTTGATTTCACCTTTCAG  
21 CGCACCGTCTTCCGGGTACATACGTTCGGTAGACGCTTCCCA  
22 ACCCATGGTTTTTTTCTGCATAACCGGACCGTCAGACGGG  
23 AAGTTGGTACCACGCAGTTTAACTTTGTAGATGAATTCACCGTCCTG   
24 CAGAGAAGAGTCCTGGGTAACGGTAACAACACCACCGTCTTCGAAG    
25 TTCATAACACGTTCCCATTTGAAACCTTCCGGGAAAGACAGTTTC     
26 AGGTAGTCCGGGATGTCCGCCGGGTGTTTAACGTACGCTTTAGAACCGT  
27 ACTGGAACTGCGGAGACAGGATGTCCCACGCGAACGGCA   
28 GCGGACCACCTTTGGTAACTTTCAGTTTCGCGGTCTGGGTACC    
29 TTCGTACGGACGACCTTCACCTTCACCTTCGATTTCGAATTCGTGA  
30 CCGTTAACAGAACCTTCCATACGAACTTTGAAACGCATGAATTCTTT  
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The top graph shows the mass spectrometry data on tetracycline while the bottom graph 
shows the mass spectrometry data on autoclaved tetracycline. ATC expected molecular 
weight 426. Tetracycline expected molecular weight 444. Conversation rates were 






OPTIMIZING RECOMBINATION PROTOCOLS 
4.1 Introduction 
 A diverse library is essential for success of directed evolution (1-3). Directed 
evolution involves i) generating a library with large diversity of variants and ii) the 
application of a screening or selection assay to pick out the improved variants (4-6). This 
sequence of diversity generation and screening or selection can be repeated iteratively a 
number of times until the improved variants are obtained. Screening and selection efforts 
are wasted if the library is not sufficiently diverse (See Figure 4.1). The two main in-vitro 
library generation methods for molecular diversity can be classified as random 
mutagenesis and recombination methods (2,3). Random mutagenesis has been reported to 
be a highly limited and biased method by recent reviews (7,8). On average, it can access 
3.14 – 7.40 amino acid substitution per residue due to the redundancy of the genetic code 
and its organization to minimize mutational errors. In contrast, recombination protocols 
have not been systematically evaluated on the same set of proteins to date. In this 
investigation, we applied two protocols, PCR based recombination and DNA shuffling, 
on fluorescent protein genes to generate libraries and will report on the performance of 






















Figure 4.1  Diagram showing the process of directed evolution. Molecular diversity is 
created and the improved variants can be found after screening and/or selection. The 
process can be iterated a number of times to obtain better variants. 
4.1.1 In-vitro library generation methods  
 There are a number of library generation methods available to date for 
recombination. Table 4.1 provides a short description of the key protocols to date. In 
general, the recombination protocols require at least one parental gene template that can 
be used as a scaffold for the creation of mutants. The library protocols usually involve a 
method to create sections of the genes that eventually get assembled together into a full-
length chimera. One key disadvantage of a number of libraries generated by some of 
these protocols such as DNA shuffling and StEP is that they contain a high percentage of 
parental background or unshuffled clones which increases the amount of effort required 
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to screen for the improved variants. 
Table 4.1  The various in-vitro recombination-protocols for library creation (3,23). 
Method Description of method and characteristics of library References 
DNA shuffling: Single 
and double stranded 
The gold standard for recombination. Involves fragmentation of 
templates by DNAse I, followed by a reassembly PCR and a 
secondary PCR to obtain gene fragments. Suffers from parental 
background. Spiked oligonucleotides can be added during primer 
synthesis to introduce diversity. 
 
CLERGY* uses DNA shuffling to generate initial diversity and 
homologous recombination during transformation in S. cerevisiae 









StEP: Single and 
double stranded 
StEP: Staggered Extension process. Short extension steps to 
promote crossovers. Suffers from parental background. Single 




SUUPER: Shuffling Using Unpaired Primers. Uses cycling 
protocols similar to StEP but involves the use of skew primers to 
force crossovers. 
(15) 
RACHITT RACHITT: Random Chimeragenesis on Transient Templates 
Uses fragmented single stranded DNA and parental DNA as 
templates to make chimera templates. High crossover frequency 
was reported for this technique.  Implementation is technically 
difficult due to the need to isolate single-stranded DNA in high 
yield 
(16) 







ITCHY: Incremental Truncation for the Creation of Hybrid 
Enzymes. SCRATCHY: Combination of ITCHY and DNA 
shuffling Two genes are incrementally truncated using nucleases 
and eventually ligated and transformed. The truncation can involve 
the use of nucleotide analogs Additionally, an in frame selection 
vector can be used to select in frame chimeras. Single crossover 
library is only possible. No sequence homology required. 
SHIPREC: Sequence Homolog-Independent Protein 
Recombination. This is a similar method to ITCHY. 
(17-22) 





4.1.2 DNA shuffling and Recombination PCR: Background and problems 
4.1.2.1 DNA shuffling background 
Since its introduction in 1994, DNA shuffling has been widely used for library 
creation (24-36). Figure 4.2 outlines the steps involved in DNA shuffling. In brief, two or 
more gene templates are fragmented using DNAse I endonuclease enzyme. After an 
assembly PCR of the fragments to generate the full-length gene and secondary PCR to 
amplify the assembled genes, chimeras are obtained. DNA shuffling has become a useful 
and standard tool for protein evolution evident from the fact that the original DNA 
shuffling papers (9,24) have been cited more than 500 times each to date. DNA shuffling, 
however, has inherent disadvantages that limit its utility as a library generation protocol. 
 
Figure 4.2  DNA shuffling and Recombination PCR (RD-PCR) are depicted on the left 
and right. DNA-shuffling involves the fragmentation of wild-type parental genes, 
followed by two PCR steps to recover the full length chimeric genes. RD-PCR involves 
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4.1.2.2 Recombination PCR: Background  
 Recombination PCR is an alternate library generation protocol recently developed 
in 2003 that is reported to eliminate parental background (15). A recent innovation 
involving the use of templates with skew annealing regions and skew primers by Ikeuchi 
et al. and Milano and Xiao (15,37), generates a library by using PCR cycling with short 
extension steps and annealing time as illustrated by Figure 4.2. Due to the use of skew 
primers, only chimeras are amplified and available for cloning with restriction enzymes. 
 Ikeuchi et al. investigated the use of skew primers, non-parental end annealing 
primers, in combination with short cycles and annealing and extension PCR cycling 
protocols on enhanced yellow fluorescent protein (EYFP) and green fluorescent protein 
(GFP) of 72% nucleotide identity (15). They obtained a library with negligible 
background and high percentage of single crossovers. They also found that recombination 
PCR required less continuous homologous nucleotide identity than DNA shuffling for 
crossovers to occur. 
 Staggered extension protocol (StEP) is a similar protocol to recombination PCR 
but it does not involve the use of skew primers to reduce parental background. Zhao et al. 
(14) described the application of StEP on two variants of thermostable subtilisin E from 
Bacillus subtilis that differ by ten point mutations. They reported generating libraries 
with 100% novel chimeras based on sequencing information from ten variants using this 
method. 
 63 
4.1.2.3 Problems with DNA shuffling and recombination PCR 
 One reported key problem with using DNA shuffling to generate a library is the 
presence of high parental background (12, 15). Parental background is the presence of 
non-shuffled templates that decreases the diversity of the library and thus, waste 
screening and/or selection efforts. A diverse library with negligible parental background 
is highly desired in protein engineering to initiate a more productive search through the 
sequence space that will increase the chances of success to obtain improved variants. 
 The lowest limits of nucleotide identity level between genes at which DNA 
shuffling and recombination PCR can still be applied is not established. With increasing 
access to homologous genes, the prospect of recombining genes with low levels (< 50%) 
nucleotide identity is becoming more likely to access a more diverse sequence space. The 
lowest reported successful DNA shuffling is 56% that led to chimera generation (51). 
 No head to head comparison of DNA shuffling and recombination PCR has been 
reported in the literature. DNA shuffling and recombination PCR have not been 
performed on the same set of proteins and the sequence diversity of the libraries produced 
by the protocols have not been analyzed extensively. It is crucial that protein engineers 
have access to information on the inherent characteristics of recombination protocols that 
may bias their sequence space exploration during directed evolution experiments. 
 The above issues inspire us to investigate the performance of DNA shuffling and 
recombination PCR protocols on fluorescent proteins.  
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4.1.3 Scope of work: Comparison of performance of DNA shuffling and 
recombination PCR on fluorescent proteins 
 The objective of this work was to compare the performance of optimized DNA 
shuffling and recombination PCR protocols on fluorescent proteins with a range of 
nucleotide identity levels from 45% to 74.5% (Table 4.2). To evaluate performance, the 
following factors were analyzed: number of crossovers, crossover points, parental 
background, chimera background, percentage of useful sequences, minimum number of 
base-pairs required for crossovers and lower limit of nucleotide identity between two 
genes required for recombination to work. To date, this is the first known head-to-head 
comparison of the performance of DNA shuffling and recombination PCR on the same 
set of proteins. It is expected that the insight gained from the characterization of this 
library will benefit the future users of DNA shuffling and recombination PCR protocols. 
In particular, the following questions will be answered: 
• Which recombination protocol is easier to apply? 
• Which protocol can still work at the lowest identity level (45%)? 
• How does the sequence diversity of the libraries generated by DNA shuffling and 
recombination PCR compare? 





Table 4.2  Nucleotide identity and amino acid identity of various pair of fluorescent 
proteins used for recombination experiments. mRFP: monomeric Red Fluorescent 
Protein, DsRed: Discosoma Red Fluorescent Protein, HcRed: Heteractis crispa Red 
Fluroescent Protein, GFP: Green Fluorescent Protein. 
Templates Nucleotide Identity (%) Amino Acid Identity (%) 
mRFP/DsRed 74.5 84.1 
DsRed/HcRed 66.6 44.8 
mRFP/GFP 45.0 24.2 
 
4.2 Materials & Methods 
4.2.1 Construction of the parental fluorescent proteins plasmids 
 The amino acid sequence of mRFP was obtained from NCBI and E. coli-codon 
optimized primers (supplement 4.7.1) were designed using DNAworks (38)  and 
synthesized. To synthesize the mRFP gene, two PCR reactions were done, one to 
assemble the codon optimized primers, and the second to amplify the full-length product. 
The gene was amplified using primers with Esp3I (italicized) restriction sites (5’ -TAC 
GTC TCG TCG ACA TGG CGT CTT CTG AAG ACG TTA TCA AAG AAT TCA 
TGC GT – 3’ and 5’ – TAC GTC TCT GGC CTA TTA CGC ACC GGT AGA GTG 
ACG ACC TTC - 3’) and digested with Esp3I enzyme and ligated using T4 DNA ligase 
into SalI and NotI digested pPROTet vector. Sequencing, expression and characterization 
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consistent with the literature confirmed that the E. coli expression optimized mRFP gene 
was successfully assembled (39).  
 The HcRed gene was cloned from pHcRed1-N1/1 plasmid (BD Biosciences 
Clontech, Plao Alto, CA) with primers containing SalI and NotI restriction sites (CGG 
GAT TCC ACA TAG TCT CAG GTA GTC GAC ATG GTG AGC GGC CTG CTG 
AAG GAG AGT ATG – 3’ and 5`- TTC CGA TAA GTT CAT AGG CCG TGG  CGG 
CCG CTC AGT TGG CCT TCT CGG GCA GGT CGC T– 3’) and cloned into the 
pPROTet plasmid. 
The GFP gene was amplified from pQBIT7-GFP plasmid (QBIOgene, Carlsbad, 
CA) primers with Esp3I restriction sites (5’ - TAC GGT TAC GTC TCG TCG ACA 
TGG CGT CTT CTG AAG ACG TTA TCA - 3’ and 5’- TAC GGT TAC GTC TCG 
TCG ACA TGG CTA GCA AAG GAG AAG AAC TCT TCA -3’), digested using Esp3I 
and ligated into SalI and NotI digested pPROTet vector. 
 The DsRed gene was amplified from DsRed2-1 plasmid (BD Biosciences 
Clontech, Palo Alto, CA) with primers containing Esp3I restriction sites (5’-TAC GGT 
TAC GTC TCG TCG ACA TGG CCT CCT CCG AGA ACG TCA -3’ and 5’-CAT TAC 
TAC GTC TCT GGC CTA CTA CAG GAA CAG GTG GTG GCG G -3’) and cloned in 
a similar way to mRFP and GFP. 
4.2.2 Template preparation for DNA shuffling 
 The mRFP, DsRed, HcRed and GFP genes were amplified by Pfu polymerase 
using primers that anneal to the pPROTet vector (5`-CTT TCG TCT TCA CCT CGA 
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GTC C-3`, 5`-CCT ACT CAG GAG AGC GTT CAC C-3`), which added 122 bp to the 
5`-terminus and 155 bp to the 3`-terminus. The PCR products were gel purified using 
1.2% agarose gel and QIAEX II kit (Qiagen, Valencia, CA). 
4.2.3 DNA shuffling 
 DNA shuffling was performed according to Joern (40), which uses a hybrid 
method derived from Stemmer et al. (9) and Abècassis et al. (41). After optimizing the 
DNaseI concentration and digestion time, 2 μg of an equimolar mixture of the desired 
parental templates was digested. Fragments of less than 300 bp were isolated by agarose 
gel purification using QIAEX II (Qiagen, Valencia, CA). 500-750 ng DNA-fragments 
were mixed with 5 μl Pfu buffer (10X reaction buffer: 100 mM KCl, 100 mM 
(NH4)2SO4, 200 mM Tris-HCl (pH 8.8), 20 mM MgSO4, 1% Triton®X-100, 1 mg/ml 
BSA), 1 μl of Pfu polymerase (2.5 U/μl) and water to a final volume of 50 μl and 
temperature-cycled following the protocol from Abècassis et al. (41): 96ºC, 90s; 35 
cycles of (94ºC, 30s; 65ºC, 90s; 62ºC, 90s; 59ºC, 90s; 53ºC, 90s; 50ºC, 90s; 47ºC, 90s; 
44ºC, 90s, 41ºC, 90s; 72ºC, 4 min); 72ºC, 7 min; 4ºC hold. Following reassembly, 1: 10, 
1: 100, 1:1000 dilutions of the reassembled fragments were amplified using nested 
primers, primers that bind within the products of the first PCR, with Pfu polymerase and 
buffer to determine the optimal dilution ratio. The genes were then amplified using the 
optimal dilution ratio. The following nested primers were used for the amplification of 
the fluorescent proteins (5`-ATG GGT CAT AAT CAT AAT CAT AAT CAT AAT C-3` 
and 5`-GTC TTT CGA CTG AGC CTT TCG T-3`). 
 68 
4.2.4 Template preparation for the recombination-dependent PCR (RD-PCR) 
 For the amplification of full-length mRFP, DsRed, HcRed and GFP genes, parent-
specific primers were designed, which added a specific overhang (either 5`-CGG GAT 
TCC ACA TAG TCT CAG GTA-3`, 5’–GCTA CGC ATG AAT GCG TAC T–3’ or 5’- 
GGA TTC CAC ATA GTC TCA GG-3’ ) at the 5`-terminus of the one parent and a 
different overhang (either 5`-TTC CGA TAA GTT CAT AGG CCG TGG-3`, 5’ – GAC 
GCT TCT GAA GAA GTC CT – 3’ or 5’-TGC CGG ATA CTT GAA TAG CC-3’ ) at 
the 3`-terminus of the other parent. The amplification of truncated mRFP, DsRed, HcRed 
and GFP genes required primers that annealed to the interior of the genes. Figure 4.3 
shows a pictorial overview of the templates used. 
                 
Figure 4.3  Various templates used for the recombination of fluorescent protein genes. 
RD-1 to RD-5 are labels given to the various combination of templates used. The black 
bars and grey bars represent double-stranded DNA of the fluorescent proteins. The 
vertical lines represent the edges of the genes. Boxes outside of the vertical lines 







truncation regions in the genes. 
 
4.2.5 Recombination PCR 
 Equimolar mixtures of the extended parental templates were used for the 
recombination PCR. Up to 50 ng of the templates were used in 25 μl reaction volumes. A 
small reaction volume ensures that thermal equilibrium is reached faster during the 
thermal cycling. 
 Two variations of Ikeuchi’s protocol (15) were used: 1) 94°C 2 min, 99 cycles of 
(94°C 1 min, 63-67°C, 5 sec), 72°C 7 min, hold at 4°C; 2) 98ºC for 5 mins; 40 cycles of 
(98ºC, 30s; 40-45ºC, 5s; 72°C for 3s); 10 cycles of (94ºC, 30s; 50ºC, 30s; and 72ºC 30s); 
hold at 4ºC.  RD-PCR reactions were performed with Taq polymerase and optimized for 
PCR yield unless otherwise specified. 
4.2.6 Sequencing 
 All sequencing was performed at the FAME Center Sequencing facility located at 
Emory University, Atlanta, GA by Perry Mars using an ABI Prism
® 
310 DNA sequencer 




 Directed evolution library generation protocols such as DNA shuffling and 
recombination PCR were applied on fluorescent protein genes from 45% to 75% DNA 
identity levels (Table 4.2). The results can be categorized into two parts; the 
recombination of fluorescent proteins with high DNA identity levels (> 70%) which 
represents the typical recombination experiments and the recombination of fluorescent 
proteins with low DNA identity levels (< 70%). Also, since DNA sequencing information 
was obtained for each clone, the parental background, crossover points, number of 
crossovers and number of mutations per variant were calculated. 390 variants were 
sequenced and analyzed. Supplement 4.7.2 contains the sequence data that are discussed 
in this section. 
4.3.1 Recombination of fluorescent proteins with high DNA identity levels (74.5%): 
mRFP and DsRed  
 The fluorescent protein genes from mRFP and DsRed were recombined using 
DNA shuffling and recombination PCR. 67 variants were sequenced from the DNA 
shuffling library and 228 variants were sequenced from the recombination PCR library. 
The recombination PCR library variants were generated using different templates to test 
the relation between the quality of the chimeras and the templates used for the 
recombination protocol and the sequencing results can be sub-divided into RD-1, RD-2, 
RD-3, RD-4 and RD-5. Figure 4.4 shows a combined plot of RD-1 to RD-4 (One skew 
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Figure 4.4  The frequency and location of crossovers in DNA shuffled and recombination 
PCR libraries made from DsRed and mRFP genes. Shaded areas indicate that the bases 
are identical in DsRed and mRFP while non-shaded areas indicate otherwise.  Crossovers 
are denoted at the position where the first base pair differs between the two sequences.  
Sequences with multiple crossovers were marked at each crossover position separately.  
‘One skew primer per parent’ combines the results from RD-PCR 1-4. A total of 295 
sequences are represented in the chart.   
 
 The DNA shuffling library had 49% parental sequences (also known as parental 
background) and this is a documented unwanted side-product as a result of using DNA 
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shuffling protocol. A similar DNA shuffling recombination experiment of green 
fluorescent protein (GFP) and yellow fluorescent protein (YFP) by Ikeuchi et al. (15) also 
had high parental background as restriction length polymorphism analysis indicated a 
fragment pattern similar to unshuffled green fluorescent protein. Other recombination 
experiments involving the use of DNA shuffling reported 20% and 16% parental 
background when genes of 2100 bp and 1500 bp are shuffled, respectively. These results 
support the view that parental background has to be expected when DNA shuffling 
protocols is used (41,42). 
 To test the correlation between the use of different templates on the 
recombination PCR protocol and the diversity of the library generated, five sets of 
recombination PCR libraries were generated using different combinations of primers as 
illustrated by Figure 4.3.  
• The first recombination PCR library (RD-PCR 1) was created using a single skew 
primer.  From the sequencing data of this library, we found zero percent parental 
background and 76% duplicate sequences, which are also termed as chimera 
background, at base pair position 6 of mRFP. Therefore, 24% of the library 
variants were useful sequences for screening, as multiplicity of the same variant 
sequence does not contribute to diversity of the library. 96% of the library had 
one crossover and four percent of library had 3 crossovers.  
• To reduce the chimera background at base-pair position 6 of mRFP, we 
performed recombination PCR using truncated DsRed templates (first five bases 
were removed) with full length mRFP templates. The sequencing data of the RD-
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PCR 2 library show that the bias could not be removed by using such a strategy. 
Of 21 variants analyzed, 43% unique chimeras were obtained. Further truncation 
of the first 44 base pairs of the DsRed parental gene (RD-PCR 3), lead to a bias 
towards crossovers at the 3’ end of the genes. However, the crossovers were not 
localized to a single position. Of the 66 variants that were sequenced, 35% were 
unique variants. When we used mRFP and DsRed truncated templates (mRFP: 
40bp 5’ end truncated, DsRed 43bp 3’end truncated) to create the RD-PCR 4 
library, we found a localization of crossovers at position 50. From 50 variants, 
35% useful sequences were found. The statistics for the library are shown in 
Figure 4.5. 
 
Figure 4.5  Distributions of DNA shuffling and recombination PCR library made from 
mRFP and DsRed genes. All the sequences are represented as a percentage of the total 
library for each set of recombination experiments. Chimera background is calculated by 
dividing the number of non-native sequences that are over-representing a crossover 
sequence by the total number of sequences for each set of library that were analyzed and 
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multiplying by a factor of 100. Useful sequences are the number of unique sequences 
over the total number of sequences for each set of library multiplied by a factor of 100. 
One, two and three crossovers percentages are calculated by dividing the number of 
sequences with one, two and three crossovers, respectively by the total number of 
sequences for each set of library and multiplied by a factor of 100. A total of 295 
sequences (67 from DNA shuffling, 228 from RDA-PCR) are represented in the graph.   
 Surprisingly, we obtained parental background in approximately 10% of 
sequences for RD-PCR 2 and RD-PCR 4 libraries, despite the expectation that the use of 
skew primers should eliminate presence of parental background as crossovers must occur 
between the templates for amplification to proceed.  
 When templates extended in both directions (RD-PCR 5) were used, parental 
background was eliminated. Of 39 colonies sequenced, 72% contained unique sequences 
with predominantly one crossover per gene. One sequence with three crossovers and one 
with five crossovers were obtained. Crossover points were also more evenly distributed 
than the other recombinant PCR libraries made using one skew primer, which tended to 
show significant bias towards the end of the genes (Figure 4.4). 
4.3.2 Recombination of fluorescent proteins with moderate DNA identity levels 
(66.6%): HcRed and DsRed 
 HcRed and DsRed genes represent a recombination scenario where there are large 
stretches of identical DNA which bias the crossovers towards these regions (Figure 4.6). 
For the DNA shuffling library, full-length HcRed and DsRed templates were used for 
recombination. Truncated gene templates of HcRed and DsRed were used for 
recombination PCR to reduce chimera background as there were large stretches of 
identical DNA regions in the front and back end of the HcRed and DsRed genes. 
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Figure 4.6  DNA alignment of DsRed/HcRed and mRFP/DsRed. Long local stretches of 
identical DNA regions can be observed in the alignment of DsRed/HcRed. 
 
 Twenty variants were sequenced for the DNA shuffling library while 23 variants 
were sequenced for the recombination PCR library. A comparison of the DNA shuffling 
library and recombination PCR library revealed that the DNA shuffling library had a 
better diversity. The DNA shuffling library has 20% parental background, ten percent 
chimera background and 70% unique sequences. Of the DNA shuffling library unique 
sequences, 50% had one crossover, 36% had two crossovers and 14% three crossovers. 
The recombination PCR library has zero percent parental background, 57% chimera 
background and 43% unique sequences. Of the recombination PCR library unique 




Figure 4.7 The frequency and location of crossovers in DNA shuffled and recombination 
PCR libraries made from HcRed and DsRed genes. A total of 43 sequences are 
represented in the chart.  
  
4.3.3 Recombination of fluorescent proteins with low DNA identity levels (45%): 
mRFP and GFP 
 To explore the lowest limit of DNA identity level where the recombination 
protocols can still be performed, the mRFP and GFP gene templates with a 45% DNA 
identity level were chosen. To date, the lowest reported successful DNA shuffling 
performed on genes was 56%  (42,44, 51). Thus, in this recombination scenario, it is not  
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immediately obvious if either of the protocols could produce useful libraries at all. 
 From the sequencing data obtained on DNA shuffling library and recombination 
PCR library, it was evident that DNA shuffling did not work on mRFP and GFP 
templates as we only found parental sequences, recombination PCR produced a library 
with zero percent parental background, 82% chimera background and 18% unique 
sequences (Figure 4.8). Of the unique sequences, all of them (100%) had one crossover. 
 
 
Figure 4.8  The frequency and location of crossovers in DNA shuffled and recombination 
PCR libraries made from mRFP and GFP genes. A total of 52 sequences are represented 
in the chart.   
 
 78 
4.3.4 Discussion of all the recombination results 
 DNA shuffling and recombination PCR were applied on mRFP/DsRed, 
HcRed/DsRed and mRFP/GFP genes. There were no clear trends observed on the effect 
of DNA identity level on the percentage of useful sequences for DNA shuffling while 
recombination PCR features a monotonic decrease of useful sequences as the DNA 
identity level decreases (Figure 4.9).  Comparison of the sequencing results across 
different levels of DNA identity levels indicate that when DNA shuffling can be used, it 
produced unique sequences with larger number of crossovers (Figure 4.10). For 
DsRed/mRFP and DsRed/HcRed DNA shuffled sequences, 52% of combined useful 
sequences featured more than one crossover while recombination PCR sequences 
featured 40% percent of combined useful sequences with more than one crossover. 
 
Figure 4.9  Distributions of useful sequences using DNA shuffling and recombination 
PCR on templates with different nucleotide identity levels. 
 79 
 
Figure 4.10  The distributions of DNA shuffling and recombination PCR library for all 
the fluorescent proteins. The various gene template combinations used for recombination 
are listed as follows: DsRed/mRFP: 75%, DsRed/HcRed: 66%, mRFP/GFP: 45% 
nucleotide identity level. 
 Overall, recombination PCR performed similarly to DNA shuffling in generating 
useful sequences. Of 289 combined sequences, recombination PCR library contained 
37% useful sequences while DNA shuffling have 45% useful sequences of 101 
sequences. To validate that the two recombination protocols produce equally useful 
number of sequences, Z-statistical analysis was performed. In this case, the null 
hypothesis states that the probability of obtaining useful sequences for both libraries is 
the same. In order to show that the two libraries are similar, it is sufficient to show that 
we cannot reject the null hypothesis. A p-value of 0.18 is obtained thus there is 
insufficient evidence that the two libraries are different, thereby validating the claim that 
the both protocols produced statistically equivalent levels of useful libraries of one or 
more crossovers. 
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Table 4.3 Overall mutation rate of DNA shuffling and recombination PCR. 
Source  Protocol  overall mutagenic rate %  Total base pairs  
mRFP and DsRed  RD-PCR 0.02  33900  
mRFP and GFP  RD-PCR 0.04  25200  
mRFP and DsRed  DNA-shuffling  0.03  21018  
mRFP and GFP  DNA-shuffling  0.02  8136  
 
  
 The analysis of the sequences reveals that the mutagenic rate in recombination 
PCR is low and comparable to typical DNA shuffling experiments. An overall mutagenic 
rate of 0.02 to 0.04 % was observed in the sequences obtained from the recombination of 
mRFP/DsRed and mRFP/GFP genes (Table 4.3). A low mutagenic rate is typically 
preferred in DNA recombination experiments to limit the search in functional space. 
Joern et al. obtained 0.011% while others have reported values between 0.05 and 0.9% 
(9, 41, 42, 45). 
4.4 Discussion 
 A systematic comparison on the performance of DNA shuffling and 
recombination PCR on producing useful libraries of fluorescent protein genes was 
performed. To date this is the first known reported head-to-head comparison of 
recombinant library generation protocols, performed on fluorescent proteins. A similar 
work was done comparing experimental and computationally generated libraries on 
fluorescent proteins by Treynor et al. (46). They compared, through experiments, 
computationally designed libraries with the libraries of randomly generated sequence 
diversity using fluorescent proteins. We found from our experiments that there were 
subtle differences in the quality of the libraries generated by the two protocols.  
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Depending on the type of gene templates used for recombination, DNA shuffling and 
recombination PCR library generation protocols perform differently. The next few 
paragraphs describe in detail, the insights gained from the recombination experiments. 
4.4.1 Library diversity: DNA shuffling and recombination PCR  
4.4.1.1 DNA shuffling and recombination PCR produced similarly useful libraries of one 
or more crossovers 
 Both DNA shuffling and recombination PCR were found to produce libraries of 
similarly useful diversity. Z-statistical analysis confirmed that both protocols produced 
equally useful libraries of one or more crossovers. From Figure 4.4, we also observe that 
recombination PCR libraries created using templates made with two-sided skew primers 
tended to have a better overall distribution of crossovers than DNA shuffling and one-
sided or truncated template recombination PCR library. We expect thus, that the 
recombination PCR with two-sided skew templates would be a better library than DNA 
shuffling due to the better distribution of crossovers. 
4.4.1.2 DNA shuffling and recombination PCR crossover tendencies 
 In general, DNA shuffling libraries are biased towards crossovers in regions of 
high nucleotide identity level (> 11 bp) as shown by Figure 4.11. Statistical analysis 
using Wilcoxon Rank Sum test on the DNA shuffled and recombination PCR libraries 
reveal that both libraries require different average lengths of nucleotide identity for 
crossovers to occur (p = 0.0004 that libraries are similar). The recombination PCR 
protocol requires shorter lengths of nucleotide identity for crossovers to occur. The 
 82 




Figure 4.11  The distributions of number of identical nucleotide base-pairs required for 
crossovers for DNA shuffling and recombination PCR on mRFP/DsRed libraries 
 
4.4.2 Recombinant PCR optimization: Two-sided skew templates libraries had the 
best diversity 
 The performance of recombination PCR is highly template-dependent. Figure 4.4 
shows that the best recombination PCR library is produced using two-sided skew 
templates (Figure 4.3). During PCR, heteroduplexing (43), a phenomenon that involves 
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skew extension without recombination via template switching, is more likely to occur 
when using one-sided skew and truncated templates than library generation using two-
sided skew templates, evident from the presence of parental background obtained in the 
sequences despite the fact that it is theoretically not possible to obtain parental genes in 
the recombination library (15). In the one-sided skew and truncated libraries, parental 
background results from the accidental amplification on an unpaired extension containing 
no crossovers. Another key advantage of using two-sided skew templates for 
recombination PCR is that different sets of skew primers can be used to change the initial 
extension point on the gene templates, thereby generating a randomized library with less 
chimera background and a more spread out crossover points (Figure 4.4). 
 Other factors that could affect the outcome of recombination PCR are the volume 
of the PCR reaction, the concentration of templates used, and the cycling protocols used 
for the PCR. Using a smaller volume ~25 μl instead of 50 μl allows the temperature of 
the cycling reaction to equilibrate faster. Using a smaller starting concentration of 
template could theoretically encourage a more diverse library to be generated as there is 
less overall starting parental templates and more newly generated chimeras templates 
relative to wild-type templates that can be used for future amplification to generate more 
sequence diversity. Also, the temperature and number of cycles could in theory be 
adjusted to obtain a library with more crossovers. However, in the course of our 
experiments, when we attempted to vary the cycling protocols, we did not get bands that 
can be cloned. As a result, we settled for optimizing the library for a good PCR band, 
although possibly, a smeared or fainter gel band could potentially have a library with 
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more chimeras. 
4.4.3 Lower identical base pairs requirement required for recombination PCR than 
DNA shuffling 
 Recombination PCR has been shown to generate useful library for a nucleotide 
identity level as low as 45% and requires lower number of identical base-pairs than 
required for DNA shuffling for crossovers to occur. From Figure 4.8, it is evident that 
recombination PCR produced chimeras, however, the utility of the libraries produced is 
questionable as only 18% unique sequences were generated. 
 The finding that recombination PCR produced chimera library with 45% 
nucleotide identity level agrees with the observation that recombination PCR requires 
lesser nucleotide identity levels for crossovers to occur than DNA shuffling (Figure 4.11). 
Figure 4.8 and Figure 4.10 show that recombination PCR is a more robust protocol and 
will produce useful libraries when nucleotide identity is as low as 45%.  
4.4.4 Inherent characteristics of recombination PCR and DNA shuffling 
 When recombining two genes, recombination PCR can only produce an odd 
number of crossovers to get amplification of the templates because of the skew annealing 
primer regions on the templates. On the other hand, DNA shuffling can produce chimeras 
with even and odd number of crossovers.  One way to overcome the potential reduction 
in diversity when using recombination PCR is to use three or more genes. With three 
gene templates, even numbers of crossovers are possible because two different gene 
templates can contain the same skew primer annealing regions that allow amplification to 
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occur. 
  DNA shuffling has parental background while recombination PCR, when 
performed under the optimized conditions described in this chapter, does not. 
Recombination by DNA shuffling relies on homologous regions annealing. In 
reassembly, the probability of the parental gene fragments annealing to reform the full 
length parental gene is energetically favored over the formation of chimeras with 
imperfect base pairing. However, a possible way to reduce parental background is to 
perform multiple rounds of DNA shuffling. 
 DNA shuffling is a difficult protocol to use compared to recombination PCR. The 
optimization of DNA shuffling is a time-consuming process that involves generating a 
high quantity of templates and a trial DNA digestion step to determine the ideal digestion 
time. Following gel purification of the digested fragments, two PCR steps are required. 
The first involves  the reassembly and the second involves amplification of the chimeras. 
Experienced users of DNA shuffling can use it as a tool for generating chimeras. Less 
experienced users, however, would stand to benefit more from recombination PCR in 
which the incorporation of skew-annealing regions into the templates and the use of 
skew-annealing primers with modified temperature protocols would produce a similarly 
useful library. It should also be noted, however, depending on the genes recombined, 
recombination PCR could potentially still require some optimization of template 
concentration and cycling conditions to produce a clonable band. 
4.5 Conclusion 
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 A controlled recombination experiment was performed using two recombination 
protocols, DNA shuffling and recombination PCR on fluorescent protein genes. 
Generally, both the protocols produced useful libraries but we found that recombination 
PCR method is an easier technique to apply. Two-sided skew annealing templates should 
be used when using the recombination PCR protocol to effectively eliminate parental 
background and to produce a library with a better crossover distribution. Also, we found 
that recombination PCR could work with genes of lower nucleotide identity level (45%) 
than DNA shuffling. 
4.5.1 Future trends: Data driven protein evolution and synthetic library 
 Recent trends in library generation involve computational analysis of the library 
that direct the generation of combinatorial libraries. Fox et al. applied 16 rounds of 
recombination on halohydrin dehalogenase proteins, obtained information about the 
important residues from computational analysis of sequence along with phenotype and 
designed libraries spiked with degenerate codons around the important residues (48). 
They obtained 4000-fold improvement on the activity of halohydrin dehalogenase 
proteins. Treynor et al. developed a structure-based algorithm that guides library design 
for fluorescent protein and found better functionality with the designed libraries than the 
randomly generated library (46). Liao et al. developed machine-learning guided 
approaches that involve analyzing the sequence-activity relationships of 59 test variants 
to design more productive libraries (47). A 20-fold improved proteinase K variant was 
obtained as a result of such an effort. 
 With decreasing costs of synthesis of whole genes, designer synthetic 
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recombination libraries can be created. It is now more economical to order 
oligonucleotides than ten years ago as the price per base-pair dropped from $4 to 
approximately $0.30 (49). In fact, there are companies such as DNA 2.0 and Codon 
Devices that synthesize more 40,000 base pairs genes routinely. Thus, individuals could 
focus on designing libraries and be less involved in the library generation process. The 
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4.7.1 E. coli expression optimized primers used for the reassembly of mRFP gene  






3 5'-AAGGTGAAGGTCGTCCGTACGAAGGTACCCAGACCGCGAAACTG   -
3' 
4 5'-AAAGTTACCAAAGGTGGTCCGCTGCCGTTCGCGTGGGAC  -3'  
5 5'-
ATCCTGTCTCCGCAGTTCCAGTACGGTTCTAAAGCGTACGTTAAACAC
CCGG  -3' 
6 5'-CGGACATCCCGGACTACCTGAAACTGTCTTTCCCGGAAGGT  -3'
  
7 5'-TTCAAATGGGAACGTGTTATGAACTTCGAAGACGGTGGTGTTGTTA  
- 3' 
8 5'-CCGTTACCCAGGACTCTTCTCTGCAGGACGGTGAATTCATCTACAA  
-3' 
9 5'-AGTTAAACTGCGTGGTACCAACTTCCCGTCTGACGGTCCGG   -3' 
10 5'-TTATGCAGAAAAAAACCATGGGTTGGGAAGCGTCTACCGAACGTAT  
-3' 
11 5'-GTACCCGGAAGACGGTGCGCTGAAAGGTGAAATCAAAATGCG  -3' 
12 5'-TCTGAAACTGAAAGACGGTGGTCACTACGACGCGGAAGTTAAAACC 
-3' 







16 5'-TTACGCACCGGTAGAGTGACGACCTTC  -3' 
17 5'-
CGCACGTTCGTACTGTTCAACGATGGTGTAGTCTTCGTTGTGAGAGGT
GAT  -3'  





19 5'-CCGGTTTTTTCGCCATGTAGGTGGTTTTAACTTCCGCGTCGTAGT  -3' 
20 5'-GACCACCGTCTTTCAGTTTCAGACGCATTTTGATTTCACCTTTCAG  -
3' 
21 5'-CGCACCGTCTTCCGGGTACATACGTTCGGTAGACGCTTCCCA  -3' 
22 5'-ACCCATGGTTTTTTTCTGCATAACCGGACCGTCAGACGGG  -3' 
23 5'-AAGTTGGTACCACGCAGTTTAACTTTGTAGATGAATTCACCGTCCTG   
-3' 
24 5'-CAGAGAAGAGTCCTGGGTAACGGTAACAACACCACCGTCTTCGAAG   
-3' 




T  -3'  
27 5'-ACTGGAACTGCGGAGACAGGATGTCCCACGCGAACGGCA   -3' 
28 5'-GCGGACCACCTTTGGTAACTTTCAGTTTCGCGGTCTGGGTACC   -3' 
29 5'-TTCGTACGGACGACCTTCACCTTCACCTTCGATTTCGAATTCGTGA  -
3' 
30 5'-CCGTTAACAGAACCTTCCATACGAACTTTGAAACGCATGAATTCTTT 
-  3’ 
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4.7.2 Sequencing data of recombination of fluorescent proteins 
Table 4.4 Sequencing results of recombination-PCR on mRFP and DsRed. mRFP: 678bp, 













DsRed 6 1 5 39 
 74.5% id 12 1 2 1 
  78 1 5 1 
  156 1 2 1 
  159 1 5 1 
  165 1 5 1 
  186 1 14 1 
  300 1 11 1 
  414 1 8 1 
  660 1 3 1 
  6, 21, 39 3 5, 4, 8 1 
  6, 248, 300 3 5, 6, 11 1 




      
RD-2 
mRFP, 
DsRed NA 0 NA 2 
              (5 Ft) 6 1 5 9 
 74.5% 7* 1 5 2 
  72 1 5 1 
  186 1 14 1 
  204 1 14 1 
  300 1 11 1 
  417 1 8 1 
  618 1 14 1 
  633 1 14 2 






DsRed 165 1 5 2 
 
             
(44Ft) 171 1 14 6 
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Table 4.4 continued     
 74.5% 186 1 14 3 
  189 1 14 1 
  204 1 14 6 
  207 1 2 1 
  247 1 6 2 
  258 1 5 1 
  300 1 11 1 
  321 1 11 1 
  348 1 11 1 
  363 1 11 1 
  366 1 2 1 
  609 1 14 2 
  618 1 14 9 
  633 1 14 10 
  636 1 8 2 
  645 1 8 6 
  648 1 2 1 
  660 1 3 1 
  664 1 3 5 
  666 1 3 2 
  
228, 240, 
264 3 5, 8, 5 1 






mRFP NA 1 NA 5 
 
(43Bt)   
(40Ft) 50 1 5 18 
  159 1 5 1 
  171 1 14 3 
  186 1 14 1 
  190 1 14 1 
  204 1 2 3 
  231 1 8 1 
  276 1 5 2 
  300 1 11 1 
  348 1 11 1 
  438 1 5 1 
  594 1 14 1 
  609 1 14 3 
  618 1 14 2 
  633 1 14 4 
  636 1 8 1 
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position 645 1 8 2 
  
78, 300, 
336 3 5, 11, 11 1 




      
RD-5 
DsRed, 
mRFP     
 
Head & tail 
extension 6 1 5 1 
  9 1 2 1 
  15 1 8 1 
  48 1 2 1 
  57 1 5 2 
  108 1 2 1 
  186 1 14 1 
  228 1 5 1 
  240 1 8 1 
  288 1 11 1 
  300 1 11 2 
  306 1 5 1 
  333 1 11 1 
  348 1 11 1 
  363 1 11 2 
  417 1 8 1 
  426 1 8 1 
  498 1 5 1 
  549 1 9 2 
  570 1 8 1 
  609 1 14 2 
  618 1 14 3 
  633 1 14 1 
  633 1 14 2 
  636 1 8 2 
  645 1 8 2 
  648 1 2 1 
  
528,535,64
8 3 3,3,2 1 
  
6,204,231,2
64,363 5 5,14,8,5,11 1 
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Table 4.4 continued     




* - frame shift with respect to DsRed 
 
 
Table 4.5  Sequencing results of DNA-shuffling on mRFP and DsRed. The crossover 














DsRed NA 0 NA 33 
 
74.5% 
id 30 1 8 1 
  39 1 8 1 
  153 1 2 1 
  171 1 14 1 
  186 1 14 3 
  247 1 6 1 
  321 1 11 1 
  417 1 8 1 
  549 1 9 1 
  589 1 3 1 
  618 1 14 2 
  633 1 14 3 
  648 1 2 1 
  90, 594 2 5,14 1 
  186, 247 2 14, 6 1 
  186, 258 2 14, 5 1 
  186, 321 2 14, 11 1 
  186, 618 2 14, 14 1 
  285, 300 2 2, 11 1 
  300, 432 2 11, 5 1 
  321,333 2 11,11 1 
  363, 589 2 11, 3 1 
  589, 594 2 3, 14 1 
  633, 645 2 14, 8 1 
  171, 393, 618 3 14, 5, 14 1 
  204, 363, 645 3 14, 11, 8 1 
  321, 609, 633 3 11, 14, 14 1 
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Table 4.5 continued     
  
84, 186, 363, 
414 4 5, 14, 11, 8 1 
  
300, 315, 363, 
636 4 
11, 11, 11, 
11 1 






Table 4.6  Sequencing results of DNA shuffling and recombination-PCR on DsRed and 
HcRed (66% sequence identity). DsRed: 678bp, HcRed: 687 bp. Crossover position with 













DsRed 46 1 5 1 
 
(93 Bt)  (44 
Ft) 50 1 25 13 
 66.0% id 86 1 15 1 
  141 1 6 1 
  148 1 6 1 
  155 1 17 1 
  174 1 17 1 
  391 1 17 2 
  409 1 17 1 
  
40, 106, 
155 3 6, 5, 17 1 
      







DsRed NA 0 NA 4 
 66.0% id 76 1 25 2 
  102 1 15 1 
  173 1 17 1 
  184 1 9 1 
  205 1 8 1 
  275 1 17 1 
  409 1 17 1 
  102, 370 2 15, 15 1 
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Table 4.6 continued     
  275, 409 2 17, 17 1 
  283, 409 2 6, 17 1 
  370, 472 2 15, 11 1 
  76, 184 2 25, 9 2 
  
76, 173, 
370 3 25, 17, 15 1 
  
76, 245, 
433 3 25, 10, 9 1 






Table 4.7  Sequencing results of DNA shuffling and recombination-PCR on mRFP and 











RD-PCR mRFP, GFP 12 1 5 30 
 45.0% id 72 1 3 1 
  106 1 9 3 
  110 1 1 1 
  294 1 3 1 
  579 1 1 1 
  661 1 2 1 





shuffling mRFP, GFP NA 0 NA 14 







4.7.3 Statistical Calculations 
4.7.3.1 Wilcoxon Rank Sum test on DNA shuffled and recombination PCR  
 The rank sum tests can be used to analyze data sets obtained independently to 
determine if they have similar distributions. The standard normal distribution can be used 
to determine the probability of two libraries being similar (50).  
 To begin with, the null hypothesis is set such that Ho: Ldnashuffling = LrecombinationPCR, 
where we assume that the distributions of libraries generated by DNA shuffling and 
recombination PCR are similar.  
 From Table 4.4 RD-5 and Table 4.5, the following data were obtained. 














14 22 10  
 The highest bp were multiplied by frequency of DNA shuffle or RD-PCR to 
combine the crossover base pairs into a single number which were then ranked. 
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Count Protocol bp*freq Protocol bp*freq
1 DNA shuffling 0 RD-PCR 0
2 DNA shuffling 6 RD-PCR 10
3 DNA shuffling 9 RD-PCR 6
4 DNA shuffling 0 RD-PCR 0
5 DNA shuffling 30 RD-PCR 40
6 DNA shuffling 12 RD-PCR 0
7 DNA shuffling 0 RD-PCR 0
8 DNA shuffling 56 RD-PCR 80
9 DNA shuffling 9 RD-PCR 18
10 DNA shuffling 0 RD-PCR 0
11 DNA shuffling 132 RD-PCR 88
12 DNA shuffling 0 RD-PCR 0
13 DNA shuffling 0 RD-PCR 0
14 DNA shuffling 308 RD-PCR 140  
 The data were then ranked. For bp*freq values which tied, the two ranks were 
averaged.  
Rank Protocol bp*freq Avg of tied values Rank Protocol bp*freq Avg of tied values
1 DNA shuffling 0 7 15 RD-PCR 6
2 DNA shuffling 0 16 DNA shuffling 9 16.5
3 DNA shuffling 0 17 DNA shuffling 9
4 DNA shuffling 0 18 RD-PCR 10
5 DNA shuffling 0 19 DNA shuffling 12
6 DNA shuffling 0 20 RD-PCR 18
7 RD-PCR 0 21 DNA shuffling 30
8 RD-PCR 0 22 RD-PCR 40
9 RD-PCR 0 23 DNA shuffling 56
10 RD-PCR 0 24 RD-PCR 80
11 RD-PCR 0 25 RD-PCR 88
12 RD-PCR 0 26 DNA shuffling 132
13 RD-PCR 0 27 RD-PCR 140
14 DNA shuffling 6 14.5 28 DNA shuffling 308  
M = number of samples for A (DNA shuffling) = 14,  
N = number of samples for B (RD-PCR) = 14 
Sa = Sum of all ranks = 7+14.5+16.5+17+18+19+20+21+22+23+24+25+26+27+28 
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I approximated 4.82 ~ 3.49 so that I can read the probability from the standard normal 
distribution table without having to calculate it. 
Two sided P-value = 2 *( 1- (Z)) = 2* (1- (3.49)) = 2*(1-(0.9998))=0.0004 
The low P-value indicates that it is the data is not statistically significant enough to 
believe that the two distributions of DNA shuffled library and recombination PCR on 
mRFP/DsRed are equal. 
4.7.3.2 Z-statistics on DNA shuffled and recombination libraries of all fluorescent 
proteins 
 The null hypothesis, is set such that H0: Pa = Pb versus Ha:Pa not equal to Pb. 
Where Pa = probability of DNA shuffling library having useful sequences with one or 
more crossovers and Pb = probability of recombination PCR library having useful 
sequences with one or more crossovers. To show that both libraries are potentially 




Protocols Label Useful 
sequences 
Label Total sequences Label Probability 
DNA shuffle x 45 45 101 Pa 0.45 
Recombination y 107 107 289 Pb 0.37 
 





















Zvalue ba  
P-value = 2 X  (-1.34) ~ approx 0.1802 (obtained from the standard normal distribution 
table) 
Thus, it is statistically significant. We cannot reject the null hypothesis. There is evidence 








DATA-DRIVEN PROTEIN ENGINEERING USING SUPPORT 
VECTOR MACHINES AND BOOLEAN LEARNING 
5.1 Introduction 
 There have been recent advances through rational design of proteins for which the 
3-D structure and amino acid residues involved in catalysis are well known (1,2). 
However, there are many proteins where the 3-D structure is not known and structure-to-
function map information is not readily accessible. In cases where these pieces of 
information are available, the engineering of these proteins is still difficult, as sequence-
function mapping cannot be easily predicted. In the absence of knowledge about a 
protein’s structure and mechanism, directed evolution can be used as a method to search 
randomly and iteratively through sequence space to find improved variants. The 
sequence-activity data obtained from directed evolution experiments can be analyzed to 
identify interacting residues and parental templates can be engineered to produce a library 
with more functional variants. A library with more functional variants improves the 
chances of success for protein engineering experiments. We will report on the application 
of such an approach on mRFP and DsRed fluorescent proteins. 
 Directed Evolution (DE) is a process in which mutations are produced, usually at 
random, in an existing protein sequence in search for a desired property (3,4). Even after 
considerable advances in library generation and screening methods (5-7), only a small 
fraction of all the possible sequences (20
L
 distinct sequences for a protein of length L) 
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can be characterized. Moreover, due to the complex nature of the sequence-to-function 
map, a majority of the mutations lead to inactive or unfolded proteins. It is known, 
however, that only a small fraction of the amino acids present in a protein contribute 
significantly to the protein’s properties (8,9). These circumstances provide the motivation 
to identify such residues, so that experiments can be done more efficiently to increase the 
chances of success.  
 It is known that there exist pairs of residues that interact with each other in a 
protein’s three-dimensional structure (10). To create active variants of a protein, it is 
important to preserve interacting residues. Figure 5.1 shows an example of a 
recombination that results in non-compatible residues at an interactive distance. Such 
residues can be identified by applying the concept of feature selection in machine 
learning to the data that are generated during DE experiments. In theory, this will 
increase the probability of finding a variant with an improved function since a larger 
number of the variants generated will be functional. Also, though not yet proven, since a 
larger number of crossovers can be generated without deactivating the proteins, 




Figure 5.1 Recombination that disrupts favorable interactions. 
 
5.1.1 Previous work performed on the topic 
5.1.1.1 Famclash: A procedure that relies on identifying residues positions in the family 
protein sequences to verify conformity to identified conserved properties from which any 
deviations are denoted as residue-residue clashes.  
 Saraf and Maranas (11) investigated a FamClash based approach that involved 
using the structure of a protein to find possible interacting residues. These pairs were 
amino acid residues spatially located close to each other in three-dimensional structures 
that seemed to have electrostatic, polar, or volumetric compatibility. Saraf and Maranas 
succeeded in predicting qualitatively the pattern of activity of protein variants of 
dihydrofolate reductases using this technique. This approach, however, is limited to 
proteins whose  highly accurate three-dimensional structure of less than 1.0 Å rmsd is 
available. Moreover, experimental data were not used to identify but only to validate the 
identified interactions.  
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5.1.1.2 SCHEMA: Clusters of bits that interact favorably. 
 Meyer et al. (10) conducted a similar study on the structure of the protein. They 
proposed a SCHEMA-guided approach that yields blocks of protein structure, which 
when swapped between parents result in the minimum amount of disruptions between 
possible interacting positions. From selection and recombination experiments done on -
lactamases, they found that SCHEMA can be used predict the functionality of variants. 
5.1.1.3 Limitations of structure based approaches 
 Besides requiring a high-resolution three-dimensional structure, another limitation 
of structure-based approaches is the fact that interaction is assumed to be possible only 
based on the spatial arrangement of the amino acids. However, it may be possible for two 
amino acids located far apart from each other in the structure to exhibit an interactive 
effect (12). This has been observed to be the case for two different pairs of amino acids in 
TEM -lactamase. In a good example of sign epistasis, whereby the sign of the fitness 
effect of a mutation is dependent on the alleles present (13), the mutation G238S in the 
wild-type is known to enhance the cefotaxime hydrolysis but simultaneously increase 
aggregation and reduce thermodynamic stability. Conversely, another mutation, M182T, 
reduces hydrolysis while reducing aggregation and increasing thermodynamic stability. 
Thus, either of these mutations alone reduce the cefotaxime resistance of TEM
wt
, but 
together, the double mutant confers increased resistance. Such interactions cannot be 
identified from three-dimensional structure alone as structure data do not indicate 
thermodynamic stability and aggregation tendency. 
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5.1.1.4 Sequence-based methods 
 Other groups have used statistical tools such as thermodynamic coupling methods 
and co-variation analysis on sequence-based data to identify interacting and important 
residues (14-20).  Suel et al. (20) used a sequence-based thermodynamic method to map 
the global network of amino acids interactions from which long-range interactions 
between amino acid can be found. This method involved the considerations of statistical 
coupling energy ( G) due to change of amino acid distribution at one position. 
Lichtarge et al. (17) identified functional interfaces by using sequence conservation data 
and mapping them onto the protein surface to predict functionally important residues. 
Gaucher et al. (15) integrated genomic information and three-dimensional structure with 
co-varion (variable rates of divergence between trees) based analysis to identify residues 
that may explain the functional differences between proteins. These techniques are very 
useful but require large amounts of sequence data on homologous proteins which are not 
always accessible. 
5.1.2 Scope of this work 
 The above factors inspire a strategy which does not rely on the availability of the 
three-dimensional structure for any protein, or the availability of large amounts of 
sequence data from homologous proteins, and is not restricted by the assumption 
requiring the interacting amino acids to be in close proximity. One solution is to apply a 
data-driven machine learning approach that can utilize the data generated during directed 
evolution (21). In this study, we report the experimental validation of a machine learning 
approach to guide directed evolution on fluorescent proteins. This approach consists of 
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generating a library of variants and assaying for phenotype. Following that, the 
interacting residues are identified by using machine learning tools (described in the next 
section) on sequence-activity data. The information can be used to engineer templates to 
preserve interactions during recombination. This results in a library with a larger fraction 
of active variants in a library. 
5.1.3 Machine learning 
5.1.3.1 Boolean learning 
 For computer and engineering applications, Boolean functions are a standard 
representational tool (22). Given a list of examples in 0’s and 1’s (Boolean form) that are 
classified as positive or negatives, a Boolean learning algorithm can establish a set of 
rules or Boolean expressions which classify all the examples correctly. One Clause At a 
Time (OCAT) is the primary algorithm used to establish Boolean functions. OCAT can 
be based on either branch-and-bound algorithm or certain heuristics (23,24).  
 One simple example serves to illustrate the Boolean learning algorithm. Figure 
5.2 shows the input (x1, x2 and x3) and output data (f(x1,x2,x3)) listed in Boolean form. 
From the table in Figure 5.2, we can observe that x1 must always be positive for the 
function f  to be positive. In addition, either x2 or x3 must also be positive at the same 
time for function f  to be positive. Thus, the Boolean function, 
)(),,( 321321 xxxxxxf = , classify all the examples correctly (where  represents 
‘AND’ and  represents ‘OR’). 
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x1 x2 x3 f(x1,x2,x3) 
0 1 1 0 
1 1 1 1 
1 0 0 0 
1 0 1 1 
1 1 0 1 
 
Figure 5.2  Example of inferring Boolean Learning function. Left: Input and output data 
in Boolean form. Right: Pictorial representation of data using logic gates. 
 
5.1.3.2 Support Vector Machines (SVMs) 
 Support vector machines (SVMs) are a form of learning algorithm based on the 
statistical learning theory (25,26). In SVM, the data are mapped from input space to the 
higher dimensional feature space, using a kernel function, so that a linear function can be 
fitted (Figure 5.3). Following minimization of the upper bound generalization error by 
using a linear classification algorithm, the linear function that best separates the data in 
that space is obtained. Typically, the number of parameters required for this function is 
equal to the size of the data set used for training, thus avoiding overfitting. SVMs have 
been widely applied in the field of pattern recognition such as face recognition and for 
secondary structure prediction of proteins (27-30). 
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Figure 5.3 An illustration of the transformation from the input space to feature space. 
Figure adapted from (21). 
 
5.1.4 Machine learning tools for Combinatorial Protein Engineering 
 Machine learning by Dubey et al. (31) was used to analyze the amino acid 
sequences and their phenotype. Dubey et al. (31) proposed a Support Vector Machines 
(SVMs) (25,26) based algorithm to identify the individual residues of a protein, which, 
when mutated, can lead to loss of its function. The data required for the algorithm were 
the sequences of positive and negative variants of a protein, usually obtained during 
directed evolution using mutagenesis or recombination. The variants were divided into 
positive and negative phenotype based on a certain threshold on their activity. This work 
was extended to show that interactions between different amino acids can also be 
identified by using Boolean learning and SVMs  (21) on sequences obtained from 
recombination. These sequences were once again divided into positive and negative 
phenotype based on their activity. This activity can be measured based on the screening 
procedure used in the Directed Evolution of any protein. The use of both positive and 
negative examples is a key distinction in light of other methods to determine interacting 
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residues and this approach can be very helpful in identifying the significance of the 
amino acids. Such an information can be obtained only through Directed Evolution and 
not from naturally existing proteins. 
 
Figure 5.4  The steps of applying Boolean learning to identify the interacting residues and 
engineering the parents to improve the recombinant library and to do a more productive 
search for improve variants through Directed Evolution. 
 
 The procedure (illustrated in Figure 5.4) begins with the recombination of two of 
more parent sequences. The generated variants are screened to establish their activity, 
stability, or other dimensions of merit. Based on a threshold value of this measure, the 
variant sequences above the threshold are considered as positive while the ones below it 
are considered as negative. It should be noted that the threshold, which can be arbitrarily 
chosen, dictates how the results are inferred. For example, if the threshold is such that 
variant with any measurable activity is positive while all the inactive variants are 
negative, then the interactions of amino acids, which are responsible to retain any activity 
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at all, will be identified. These variant sequences are used as an input for the algorithm 
developed by Dubey et al. (21). This algorithm can then identify the significant 
interactions. It is assumed that all the important interactions have to be preserved for any 
variant sequence to show positive. phenotype An interaction is assumed to be preserved if 
both the amino acids in any variant come from the same parent.  
 Dubey et al. (21) showed through simulations that any pair of residues in the 
sequence which show interaction or epistasis can be effectively identified, independent of 
the specific location of these residues in the sequence. It was also suggested that, 
following this result, the parents can be altered to increase the fraction of positive 
variants in the recombinant library (Figure 5.4). This was achieved by mutating the 
amino acids involved in an interaction for any one parent sequence to create a double 
mutant, such that they are the same as those in the sequence of the other parent. 
Simulations showed that a recombination between this double mutant of one parent and 
the native sequence of the other can increase the fraction of positive variants since the 
interaction cannot be broken through crossovers. 
5.1.5 Fluorescent proteins as a model for experimental validation 
 To apply the approach described above to variant sequences obtained for 
fluorescent proteins, two fluorescent proteins were chosen, monomeric Red Fluorescent 
Protein (mRFP) and Discosoma Red Fluorescent Protein (DsRed). Fluorescent proteins 
are a class of proteins important for bio-imaging applications such as gene expression, 
protein-protein interaction detection, cell and protein tracking (32). They consist of -can 
structures that encase a chromophore. The encased chromophore undergoes a series of 
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maturation steps that extend the conjugated double bonds, producing fluorescence. The 
functionality of fluorescent protein can easily be detected by measuring fluorescence. 
This assay provides an effective screen for establishing whether a variant sequence is 
folded or not.  
 Both mRFP and DsRed are well characterized proteins and have distinct spectral 
emissions (33,34). mRFP emits with a maximum fluorescence at 607 nm while DsRed 
emits with a maximum peak at 583 nm. mRFP is derived from DsRed protein (33) by the 
introduction of 33 mutations which include aggregation-disrupting changes such as R2A, 
K5E, N6D, I125R, V127T, R153E, H162K, A164R, L174D, I180T, Y192A, Y194K, 
H222S, L223T, F224G and L225A. Thus, both proteins share a high level of amino acid 
identity of 84.1%. The mRFP we used was codon-optimized for expression in E. coli 
while the DsRed gene was optimized for mammalian expression. This gave us a gene set 
with 74.5% nucleotide identity level. 
 
5.2 Materials & Methods 
5.2.1 Materials 
 Most of the enzymes were bought from New England Biolabs (Beverly, MA), 
with the exception of Pfu and Taq polymerase, which were purchased from Stratagene 
(La, Jolla, California). Tetracycline, ampicillin and chloramphenicol were purchased 
from Sigma (St. Louis, Missouri). The inducer, anhydrotetracycline (ACT) was made by 
dissolving 250 mg/l of tetracycline in water and adjusted to pH 3 and autoclaving for 45 
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mins (35). 
5.2.2 Parental plasmids construction 
 The mRFP amino acid sequence was obtained from NCBI and E . coli-codon 
optimized primers were designed using DNAworks (36) and synthesized. After two PCR 
reactions, the mRFP gene was obtained and reamplified with primers with Esp3I 
restriction sites (5' - TAC GTC TCG TCG ACA TGG CGT CTT CTG AAG ACG TTA 
TCA AAG AAT TCA TGC GT - 3' and 5' - TAC GTC TCT GGC CTA TTA CGC 
ACC GGT AGA GTG ACG ACC TTC - 3'), digested with Esp3I enzymes and cloned 
into SalI and NotI restriction sites of digested pPROTet vector using T4 DNA ligase. 
DH5 pro E. coli strains were used for transformation. The mRFP gene is successfully 
obtained, evident from sequencing data. We can obtain up to 20% of total protein 
expression of mRFP in cells. The excitation and emission spectral of the fluorescent 
protein were identical with the literature (33). 
 The DsRed gene was amplified with primers that contain Esp3I restriction sites 
(5' - TAC GGT TAC GTC TCG TCG ACA TGG CCT CCT CCG AGA ACG TCA - 3' 
and 5' CAT TAC TAC GTC TCT GGC CTA CTA CAG GAA CAG GTG GTG GCG G 
- 3) from DsRed2-1 plasmid (BD Biosciences Clontech, San Jose, California). The 
DsRed insert was digested with Esp3I enzyme and cloned into SalI and NotI site of 
digested pPROTet vector using T4 DNA ligase. 
5.2.3 Templates for DNA-shuffling 
 The mRFP and DsRed genes were amplified by Pfu polymerase using pPROTeT 
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vector specific primers (5`-CTT TCG TCT TCA CCT CGA GTC C-3`, 5`-CCT ACT 
CAG GAG AGC GTT CAC C-3`) that add 122 bp to the 5'-terminus and 155 bp to the 3'-
terminus. The PCR products were gel purified thereafter. 
5.2.4 DNA-shuffling procedure 
 A hybrid method for DNA-shuffling from (37) was used. We used up to 4 μg of 
templates for DNase I digestion. The digestion time was optimized to produce fragments 
of around 50 bp. The resultant fragments were agarose gel-purified using QIAEX II
® 
Gel 
Extraction Kit (Qiagen, Valencia, California). The purified fragments were mixed with 
5μl of 10X Pfu buffer and water to a final volume of 50 μl and cycled using the protocol 
from (38); 96
o
C, 90s; 35 cycles of (94
 o
C, 30 s; 65
 o
C, 90 s; 62
 o













C, 90 s; 72
 o
C, 4 min); 72
 o
C, 7 min; 4
 o
C 
hold. Nested primers (5'-ATG GGT CAT AAT CAT AAT CAT AAT CAT AAT C-3', 5'-
GTC TTT CGA CTG AGC CTT TCG T-3') were used to amplify the genes from the 
diluted reassembled products. 
5.2.5. Templates for RDA-PCR 
 Parent-specific skew primers were designed which added overhangs to the 5'-
terminus (5'- CGG GAT TCC ACA TAG TCT CAG GTA-3') and 3'-terminus (5'-TTC 
CGA TAA GTT CAT AGG CCG TGG-3') to mRFP and DsRed genes, respectively. 
5.2.6. Recombination dependent-PCR procedure 
 An adaptation of protocol by Ikeuchi et al.(39) for recombination was followed. 
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Taq DNA polymerase was used and the PCR was optimized for a higher yield of 
crossovers. The cycling protocols used are as follows: 98 C for 5 mins; 40 cycles of 
(94 C, 30 s; 40-45 C, 5 s; 72 C for 3s); 10 cycles of (94 C, 30s; 50 C, 30s; and 72 C for 
30 s); 4 C hold. 2) 95 C, 2 mins; 20 cycles of (95 C, 30 s; 60-67 C, 1+1 s); 60 cycles of 
(95 C, 30s, 60-67 C, 20 s); 72 C, 10 mins. 3) 95 C, 2 mins; 99 cycles of (95 C, 30 s; 
65 C, 20 s); 72 C for 10 mins.  
5.2.7. Creation of point mutation variants of mRFP and DsRed 
 The Stratagene Quickchange
®
 site-directed mutagenesis protocol was used to 
create single and double mutants. Sense and anti-sense primers of the point mutations to 
be introduced were designed and synthesized. The mutations introduced into mRFP are 
I197A (5' - TGC GTA CAA AAC CGA CGC CAA ACT GGA CAT CAC CTC TC - 3', 
5' - GAG AGG TGA TGT CCA GTT TGG CGT CGG TTT TGT ACG CA - 3'), A217T 
(5' - CGT TGA ACA GTA CGA ACG TAC CGA AGG TCG TCA CTC TAC CG - 3', 5' 
– CGG TAG AGT GAC GAC CTT CGG TAC GTT CGT ACT GTT CAA CG - 3'), 
L83K (5'- ACC CGG CGG ACA TCC CGG ACT ACA AGA AAC TGT CTT TCC 
CGG AAG GTT TCA - 3', 5' - TGA AAC CTT CCG GGA AAG ACA GTT TCT TGT 
AGT CCG GGA TGT CCG CCG GGT - 3') for single mutants, I197A/A217T (double 
mutants), I197A/L83K, A217T/L83K and I197A/L83K/A217T (triple mutants). The 
mutations introduced into DsRed are A197I (5' - CGG CTA CTA CTA CGT GGA CAT 
CAA GCT GGA CAT CAC CTC C - 3',5' - GGA GGT GAT GTC CAG CTT GAT GTC 
CAC GTA GTA GTA GCC G - 3' ),T217A (5' - GGA GCA GTA CGA GCG CGC CGA 
GGG CCG CCA CCA C - 3', 5' - GTG GTG GCG GCC CTC GGC GCG CTC GTA 
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CTG CTC C - 3'), K83L (5' - ACC CCG CCG ACA TCC CCG ACT ACC TGA AGC 
TGT CCT TCC CCG AGG GCT T, 5' – AAG CCC TCG GGG AAG GAC AGC TTC 
AGG TAG TCG GGG ATG TCG GCG GGG T - 3'), A197I/T217A, A197I/K83L, 
A217A/K83L and A197I/K83L/A217A. 
5.2.8 Expression normalization and determination of phenotype on Fluorescent 
Proteins 
 The PCR products from DNA-shuffling or recombination dependent-PCR were 
cloned into the  SalI and NotI or AseI restriction sites of digested pPROTet using the 
respective restriction endonucleases and T4 DNA ligase. DH5 pro E.coli cells were 
transformed with recombinant vectors using standard chemical protocol (40) and plated 
on 20 μg/mL chloramphenicol LB plates. The generation of a diverse library is confirmed 
by sequencing at least 10 randomly picked colonies. To ensure that the expression levels 
of the fluorescent proteins in the cell cultures are normalized, we followed the protocols 
described in (41). Briefly, random colonies of mRFP and DsRed chimeras were either 
hand-picked or robot-picked using QPix2 colony picking machine (Genetix, Boston, 
Massachusetts) from chloramphenicol plates and incubated for 24 hrs at 37
o
C and 150 
rpm until growth reached the stationary phase of E. coli. Twenty μl of culture were 
transferred to another 96-well plate containing 180 μl of LB supplemented with 
choloramphenicol and ACT to induce protein expression. The transferred cultures were 
incubated 37
 o
C and shaken at 150 rpm. After 30 hours, the emission-spectrum scan 
(excitation 540 nm, emission 500-700 nm range) using SPECTRAmax GEMINI 
(Molecular Devices Corp, Sunnyvale, California) was obtained. Positive controls of 
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mRFP, DsRed and GFP recombinants and negative controls using LB blanks were also 
measured. Since the peak fluorescence for mRFP (607 nm) and DsRed (583 nm) differ, to 
classify a variant as active or inactive, its measured fluorescence intensity was first 
matched with the appropriate parent and then the peak intensity was compared. Several 
variants were found which did not share the peak wavelength with any of the parent. For 
such cases, it was decided that the peak intensity will be compared to the parent with the 
lower intensity. This decision, however, was not critical in classifying the variants into 
positive and negative since the difference between the active and inactive variants was 
very pronounced (see Results and Discussion) 
5.2.9 Applying Boolean learning and BLSVM 
 For Boolean learning these variant sequences were transformed into Boolean 
vectors as described in Appendix 5.8.1 and the OCAT algorithm was used on the data set 
of sequences. Along with Boolean learning, the BLSVM algorithm, which was described 
in Appendix A.1, was also used on the same data set. The Boolean function given in 
Equation A.1 was identified by these two algorithms from 83 variant sequences. The 
weighing parameter for BLSVM in Equation (A.5) was set equal to 2 based on the 
simulation results of Dubey et al (21). The Lagrangian variables, , were obtained by 
using SVMs on the data set of variant sequences. Since, as discussed in Appendix A.2, 
the input data needs to be in the form of vectors, x, the sequences were represented as a 
vector of amino acids. The naturally occurring amino acid residues were represented by 
numbers from 1 to 20 in the input variant sequences (Dubey et al (21)). A polynomial 
kernel (Appendix A.2), 2)1(),( jiji xxxxK += , was used since it can account for 
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interactions between different attributes of the positions of the sequence (21). The 
optimization problem of Equation (A.4) was solved by using Sequential Minimal 
Optimization (42) in MATLAB
®
. 
5.2.10. Random Sampling of Variant Libraries 
 In random sampling, multiple samples of the two initial sets are created by first 
combining them, and then randomly splitting them in two different sets. This process is 
performed without replacement, so, any point can belong to either of the set but not to 
both of them. This procedure is repeated for a large number of times and for each split, 
the difference in the means, d, is recorded. From the resulting distribution of d, it is 
possible to calculate the probability of obtaining the difference greater than or equal to 
the one between the original sets. If this probability is below a certain threshold, , the 
null hypothesis can be rejected.  
5.3 Results 
5.3.1 Amino acid residues 197 and 217 are identified as interacting 
 The sequence-activity relationships of 83 variants were obtained from 
recombination and expression experiments. DNA shuffling and recombination-PCR were 
applied to mRFP and DsRed fluorescent proteins to obtain chimeras which were then 
expressed in 96 well plates.  Figure 5.5 shows the distribution of the crossovers obtained 
for the 83 variants with an average of 1.73 crossover for the set. Most of the variants (> 
60%) of the variants had one crossover. The detailed crossover positions can be found in 
the Supplement Table 5.7.1. The relative fluorescence intensities of the variants were 
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plotted in Figure 5.6. Since fluorescence intensity is a property that depends on 
experimental conditions, we plotted the fluorescence intensities relative to the parental 
wild-type fluorescence to reduce experimental noise and to normalize the fluorescence 
intensity to a standard reference.  If the peak wavelength of the fluorescence intensity of 
the variant did not match either parent, then it was normalized relative to the parent with 
the lower wavelength. The solid lines indicate the wildtype fluorescence of mRFP or 
DsRed protein and the cutoff for deciding activity which was set at ten percent of WT 
fluorescence. It can be observed from Figure 5.6 that there are no variants very close to 
the cutoff value. The classifications are thus resistant to fluctuations of fluorescence 
intensities and the decision to compare the intensity of the variants which did not match 





Figure 5.5  The distributions of crossovers in the variants.  
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 The sequence-activity relationships data was analyzed using machine learning 
algorithms and residues 197 and 217 were identified as interacting. Dubey et al. (21) 
determined through simulations that for sequences comparable to mRFP and DsRed 
proteins, which consist of 225 amino acids, on the order of 100- 200 sequences were 
required for reasonably accurate identification of the Boolean function. We used 83 
sequences for the computations, which is similar to the number required. In the mRFP 
protein, isoleucine and alanine were in positions 197 and 217, respectively. For the 
DsRed protein, alanine and threonine were in positions 197 and 217, respectively. 
 
Figure 5.6  The Fraction Peak Intensity of variants. The different geometric symbols 




5.3.2 Validating the interactions through point mutations 
 Evidence of interactions between the residues was checked by introducing single 
and double point mutations at the residue positions 197 and 217. If there are interactions 
between these residues, then single point mutation variants should be inactive as the 
interactions are disrupted. However, if double point mutants are created such that both 
the residues are swapped for the residues in the other parents, we should expect to see 
active proteins as the interactions were preserved. Site-directed mutagenesis was used to 
create point mutants which were fluorimetrically assayed for function. Five different 
colonies containing the same recombinant protein were scanned for fluorescence. The 
results were averaged to account for experimental noise. Table 5.1 summarizes the results 
obtained. 
Table 5.1  Relative fluorescence of the various single and double point mutants of mRFP 
and DsRed proteins. 
Variant % WT intensity Active? Predicted 
mRFP-I197A 0 No No 
mRFP-A217T 0 No No 
DsRed-A197I 0 No No 
DsRed-T217A 30 Yes No 
mRFP-I197A/A217T 0 No Yes 
DsRed-A197I/T217A 12 Yes Yes 
 
 As expected, mRFP single mutants, I197A, A217T and DsRed single mutant 
A197I were inactive. Surprisingly, DsRed T217A single mutation seemed to be tolerated 
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although the fluorescence intensity relative to DsRed wild-type seemed to be reduced. 
The double mutation in mRFP unexpectedly was also not active. However, the double 
mutation in DsRed was indeed active which demonstrates interaction between the two 
residues. If there were no interaction between A197 and T217, then the combined effort 
of mutating them should be linear and the double mutant should be inactive since A197I 
renders DsRed non-fluorescent. The fluorescence of the double mutant can be viewed as 
a clear sign of interaction between the two amino acid residues since both the individual 
mutations have a negative effect on the fluorescence. 
5.3.3 Using three-dimensional structures to find interactions to check our 
predictions 
 We analyzed the 3D crystal structures of DsRed protein to determine if it was 
necessary for the residues to be geometrically located next to each other for interaction to 
occur. To date, the mRFP crystal structure has not been published; an analysis of the 
residues involved in interactions cannot be performed by simply mutating the DsRed 
crystal 3D structures. We used comparative modeling, threading and Ab initio structure 
prediction to obtain the mRFP structure (43-47). These programs required the crystal 
structure or amino acid sequence information along the desired mutations for input. All 
these methods yielded low resolution -can protein structures that did not provide the 
accuracy for probing interacting sites. 
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Figure 5.7  Native DsRed structure with T217A mutation illustrated using Rasmol. The 
threonine residue is colored green while the new alanine reisdue is colored red. Steric 
conflict is not observed. Variant is active as a result. 
 
 The next best alternative to find possible interacting sites is to use the DsRed 
fluorescent protein structure. The mRFP and DsRed fluorescent proteins differ by 33 
amino acids, thus it is likely they will only have a slightly different fold. Nonetheless, we 
noticed that the key residue 83 that has been known to affect the emission wavelength is 
different in mRFP (leucine) and DsRed (lysine). The side chain of residue 83 is very 
close to the chromophore as well as to the residues 70, 197 and 217 (Figure 5.7 – 5.8). 
The smaller L83 residue in mRFP reduces hydrophobic core packing that could 
potentially affect the interaction with residue 70 and eventually disrupt chromophore 
maturation. Thus, the chromophore in mRFP is possibly less tolerant of disruptions in 
both the residues 197 and 217. From the three-dimensional structure alone, this finding 
may also suggest that residue 83 can possibly interact with either one of the residues 197 
and 217. Note that this residue was not identified by the algorithm to be interacting. 
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Figure 5.8  Native S197A modified DsRed structure with A197I point mutation. This 
mutation effectively mutates the mutant back to native residue isoleucine (A-green, I-
red). Possible steric hindrance with isoleucine observed. 
 
 Experiments were performed to check whether there could be interactions 
involving residue 83, additional point mutants and double mutants were created and 
tested for activity. The results for these mutations are listed in Table 5.2. Evidently, L83 
is individually important for mRFP since a mutation in that position deactivates the 
protein. There is no evidence of its interaction with residue I197 since the double and the 
triple mutants are also inactive. Likewise, in DsRed, the K83 residue also affects the 
activity because a mutation reduced the intensity (but does not deactivate it). Mutating 
the active double variant DsRed-A197I/T217A (Table 5.2) at position 83 yielded a triple 
variant of DsRed  with <10% intensity, thus rendering the triple variant inactive 
according to our threshold. Thus, there is no indication that residue 83 is interacting with 




Table 5.2  Single, double and triple point mutants in positions  83, 197 and 217 of mRFP 
and DsRed. 
Variant % WT 
intensity 
Active? 
mRFP-L83K 0 No 
mRFP-L83K/I197A 0 No 
mRFP-L83K/A217T 0 No 
DsRed-K83L ~20 Yes 
DsRed-K83L/A197I 0 No 








5.3.4 Increased fraction of active variants in engineered library 
 Identification of interacting residues is suggested to aid in directed evolution 
efforts. Dubey et. al (21) suggested a multi-round strategy for using the identification of 
interacting residues to improve the library of the variants in each round. If point 
mutations were introduced in the identified pair such that both the parents have the same 
amino acids, one should expect an increase of the fraction of active variants after 
recombination of the engineered templates when compared to the library created through 
the recombination of wild-type templates. Efforts are thus better utilized to search for 
sequences in the active regions of the sequence space. The improvement in productive 
search through active space should improve the odds of obtaining a desired variant. 
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 Recombination was applied to WT mRFP and DsRed templates and WT mRFP 
and engineered DsRed templates to verify that libraries with preserved interactions were 
more active. DNA shuffling was used on mRFP and active double mutant DsRed-
A197I/T217 and mRFP and DsRed wild-type to generate two sets of recombinant 
libraries. For each set of libraries, 480 randomly picked variants were screened for 
fluorescence. To ensure that crossovers occur between residues 197 and 217, we 
sequenced randomly picked variants from the native and engineered library. Table 5.3 
shows the results of sequencing. We found 33% crossovers occurring between these 
amino acids which suggests that recombination is breaking the interactions between 
residues 197 and 217. The fraction of active variants (at least 10% of wild-type) was 49% 
for the wild-type recombinant library while the fraction was 67.5% for the engineered 
library. 
 To determine whether the results that show a library with higher fraction of active 
variants was obtained with the engineered templates were statistically significant, testing 
of the null hypothesis by random sampling was performed (48). The null hypothesis was 
defined as the assumption that the two different set of results obtained on the fraction of 
active variants for the WT library and engineered library are the same and any point in 
one of those sets can belong to either of them. To claim that the two sets are indeed 
different, it is sufficient to disprove the null hypothesis. Note that since there are a limited 
number of points in each set, simply comparing the means without further sampling is not 
statistically sufficient.  
 131 
 The two sets in this study are the active and inactive variants obtained by the 
recombination of mRFP/DsRed and mRFP/DsRed-A197I/T217A. An active variant was 
represented by 1 and an inactive variant by 0, so that each set had 480 binary numbers. 
Even when 10
5
 different random samples were created, the probability of getting sets 
more different than the obtained sets was found to be  equal to zero. Thus, the 
probability, p is less than 10
-5
. From random sampling, the probability of the null 
hypothesis was found to be less than 10
-5
. Conventionally, the null hypothesis is rejected 
if the probability is less than or equal to 0.05. Thus, it can be concluded that the 
difference in the results of recombination from the two different pairs of parents is 
statistically significant. 
Table 5.3  The sequences of recombinant libraries of WT library and engineered library 
generated by DNA-shuffling 
Library Sample no. Starts with Crossover positions No. of Crossovers Crossover between 197 and 217
WT 1 mRFP NA 0
WT 2 mRFP NA 0
WT 3 mRFP NA 0
WT 4 mRFP NA 0
WT 5 mRFP 39 1
WT 6 mRFP 321 1
WT 7 mRFP 549 1
WT 8 mRFP 618 1 X
WT 9 mRFP 186, 247 2
WT 10 mRFP 285, 300 2
WT 11 DsRed 300,432 2
WT 12 mRFP 204, 363, 645 3 X
WT 13 DsRed 321, 609, 633 3 X
Variants total 9
Variants with crossover between residue 197 and 217 3






Table 5.3 continued 
Library Sample no. Starts with Crossover positions No. of Crossovers Crossover between 197 and 217
EN 1 mRFP 153 1
EN 2 mRFP 171 1
EN 3 mRFP 186 1
EN 4 mRFP 186 1
EN 5 mRFP 186 1
EN 6 mRFP 247 1
EN 7 mRFP 633 1 X
EN 8 mRFP 186, 322 2
EN 9 mRFP 186, 618 2 X
EN 10 mRFP 363, 589 2
EN 11 DsRed 589, 594 2 X
EN 12 mRFP 633, 645 2
EN 13 DsRed 171, 393, 618 3 X
EN 14 mRFP 84, 186, 363, 414 4
EN 15 mRFP 300, 315, 363, 636 3 X
Variants total 15
Variants with crossover between residue 197 and 217 5
%Variants with crossover between residue 197 and 217 33.3  
5.4 Discussion 
5.4.1 Importance of residues 197 and 217 for mRFP and DsRed 
 The three-dimensional crystal structure of DsRed fluorescent protein (1G7K) 
obtained from the Protein Data Bank (PDB) can be used to study the positioning of the 
interacting pair of amino acids. It should be noted that no crystal structures were used 
initially to identify the interacting amino acids. Figure 5.9(a) shows the two residues 
highlighted in white within the core of DsRed fluorescent protein. The two residues are 
very close spatially. The distance between the side chains is 3.79Å (O  of T197 to C  of 
A217). The chromophore is shown in blue while the residue K70 is colored red. Figure 
5.9(b) shows an enlarged view of the residues 197 and 217 along with K70. It is 
interesting to note that both of these residues are very close (O  of T217 to N  of K70 – 
3.74 Å and C  of A197 to N  of K70-4.22 Å) to K70, which has been known to exert a 
significant influence on the maturation of the chromophore.  
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 Residues 197 and 217 have been reported to be involved in stabilizing the anion 
form of the chromophore (33,34,49,50) which corroborates the prediction that residues 
197 and 217 could be interacting. Campbell et al. found in the course of evolving mRFP 
from DsRed, that residues K70, S197 and T217 were important residues that affect the 
fluorescent properties of DsRed mutants (33).Verkhusha and Sorkin analyzed the 
residues spatially close to the chormophore and determined the 146, 161 and 197 residues 
(relative to DsRed) were the main molecular photoconversion determinants for tetrameric 
fluorescent proteins (50) and created a photoactivatable probe by mutating the mRFP 
protein in these three positions 146, 161 and 197. Yarbrough et al. crystallized DsRed 
fluorescent protein and mentioned that S197 residue of DsRed interacts indirectly 
through a water molecule with K70 residue. Replacing S197T affected the final 
maturation of DsRed fluorescent protein (49). Lastly, Baird et al. characterized DsRed 
fluorescent protein mutants and found S197T mutation increased maturation time of 
DsRed fluorescent protein (34). 
   
Figure 5.9  (a) Left: The crystal structure of DsRed with the residues in positions 197 and 
217 highlighted. The residues 197 and 217 are shown in white. K70 and the chromophore 
are colored in blue and red respectively. (b) Right: Enlarged view of interacting residues 
197A and 217T with K70 highlighted. 
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5.4.2 Nature of interactions 
 The exact nature of the interaction could not be determined, but they could be 
interacting indirectly through the K70 residue (49). The K70 network has been known to 
affect to affect the maturation of DsRed. Since K70 was conserved between the two 
sequences, it is possible that the difference in the residues in position 197 and 217 
compensate for each other. Such compensating effects, where the loss of fitness through 
one point mutation can be counteracted by another, have been demonstrated before. 
Jucovic and Poteete (51) deactivated lysozyme by a single mutation and recovered its 
function through two additional point mutations. In nature, compensating mutations have 
been found in elongation factors and in orthologs of related species (52,53). Weinreich et 
al. discovered compensatory mutations in TEM-1 -lactamase where the additive effects 
of the combination of G238S and M182T point mutations increased activity towards 
cefotaxime. 
 To explain the unexpected fluorescence of DsRed T217A, the DsRed crystal 
structure was analyzed to gain insight. The mutation function of Swiss-PDBViewer (54) 
was used to produce the point variants T217A and A197I from the native structure of 
DsRed. Figure 5.7 show that the T217A mutation does not seem to cause steric hindrance 
with either K70 or the chromophore (66-68). The lack of steric hindrance, thus, may still 
allow for full red chromophore maturation. The reduced intensity could result from the 
loss of hydrophobic packing that results in the chromophore not optimally positioned for 
the extension of the conjugated bonds that confers red fluorescence (32,34,55). The 
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DsRed A197I mutation on the other hand, seems to result in a structure which displays 
steric hindrance by I197 on the chromophore as shown in Figure 5.8  and thus results in 
an inactive variant. 
 It is also possible that interaction between residue 197 and 217 exists in DsRed 
but not mRFP, even though the two fluorescent proteins feature 84.1% identity. The 
sequence-activity relationship could be different for mRFP and DsRed protein despite the 
high level of identity. Since the library which was used as input for the algorithm to 
determine potentially interacting residues consisted of DsRed and mRFP chimeras, pairs 
that are important to one parent would still be identified by the algorithm since there 
would be loss of function in the recombined variant. Table 5.1 shows that the double 
point mutant of DsRed is active while the double point mutant of mRFP was inactive. 
This demonstrates that interaction was occurring between residues 197 and 217 for 
DsRed fluorescent protein while the evidence for interaction for mRFP is not as strong.  
5.4.3 Usefulness of BLSVM for directed evolution 
 While a library with improved fraction of active variants could be obtained by 
engineering the templates to preserve the interactions, it is not necessary evident that such 
a technique would be useful for evolving proteins with higher activities. In the current 
study, we screened for a library with a larger fraction of positives instead of a library with 
higher activity level. The objective of obtaining a library with a higher fraction of active 
variants was achieved. Though not yet demonstrated in this study, such a library could be 
potentially useful for evolving protein towards different substrate specificities as the 
evolution of different substrate specificity could decrease native activity. Conceivably, an 
improved variant of a protein would strengthen the case for using machine learning 
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algorithm to identify important and interacting residues and guide directed evolution 
efforts. 
5.4.4 Examples of data-driven protein engineering 
 Two recent publications highlight the usefulness of using computational 
algorithm on experimentally obtained sequence-activity relationships to find residues 
crucial for protein evolution. These proprietary algorithms were developed in protein 
engineering firms. Fox et al. (56) demonstrated the use of regression analysis in parallel 
to recombination experiments to identify residues that tend to increase the overall activity 
of the protein. They evolved an improved halohydrin dehalogenase that is 4000-fold 
more active than wild-type protein. Liao et. al. (57) used machine learning language 
along with a synthetic library to engineer the proteinase K protein. They showed that 
using only two cycles of protein evolution with machine learning guided approach and 
only testing just 95 variants, they could obtain proteinase K variants with 20 fold 
improvement relative to the wild-type protein with respect to specific activity on the 
hydrolysis of a tetrapeptide substrate (N-Succinyl-Ala-Ala-Pro-Leu p-nitroanilide). 
5.5 Conclusion 
 A method involving the use of Boolean learning (BL) and Support Vector 
Machines (SVMs) (= BLSVM) to identify potentially interacting residues using 
sequence-activity data on mRFP and DsRed fluorescent proteins was demonstrated in this 
study. Single, double and triple point mutants of the fluorescent proteins in positions 83, 
197, and 217 were created to test the predictions. All the single mutants except the 
T217A DsRed variant were inactivated as expected. This might be explained by the lack 
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of steric hindrance on the chromophore by the mutation. The DsRed variant, 
A197I/T217A was active as expected but surprisingly, the double point mRFP variant 
I197A/A217T is inactive possibly due to less tolerant hydrophobic interactions. The 
evidence of non-linear effects of A197I/T217A DsRed variant suggests interaction do 
occur between residues 197 and 217. We show that using geometric proximity in three-
dimensional crystal structure is not a good way to find interacting residues. The results 
were also used to improve the fraction of active variants by preserving the interactions of 
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5.7.1 The input data for BLSVM analysis - Sequence-activity data used as input to 
BLSVM to identify interacting residues. Interactions are preserved when residues 
197 (589-591bp) and 217 (649-651bp) are from the same parents. 
S No. Starts with 
Crossover position 
DNA 
No. of Crossovers Function 
Interactions 
preserved? 
1 mRFP 6 1 Y Y 
2 dsRed 6 1 Y Y 
3 mRFP 12 1 Y Y 
4 dsRed 31 1 Y Y 
5 mRFP 72 1 Y Y 
6 mRFP 78 1 Y Y 
7 dsRed 141 1 Y Y 
8 dsRed 153 1 Y Y 
9 mRFP 156 1 Y Y 
10 mRFP 159 1 Y Y 
11 dsRed 159 1 Y Y 
12 mRFP 165 1 Y Y 
13 mRFP 171 1 Y Y 
14 dsRed 171 1 Y Y 
15 mRFP 186 1 Y Y 
16 dsRed 186 1 Y Y 
17 dsRed 190 1 Y Y 
18 mRFP 204 1 Y Y 
19 dsRed 204 1 Y Y 
20 mRFP 207 1 Y Y 
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5.7.1 continued     
21 dsRed 229 1 N Y 
22 dsRed 231 1 Y Y 
23 mRFP 276 1 Y Y 
24 dsRed 276 1 Y Y 
25 mRFP 282 1 Y Y 
26 mRFP 300 1 N Y 
27 dsRed 300 1 N Y 
28 dsRed 348 1 N Y 
29 mRFP 414 1 Y Y 
30 mRFP 418 1 Y Y 
31 mRFP 435 1 Y Y 
32 dsRed 439 1 N Y 
33 mRFP 549 1 N Y 
34 mRFP 589 1 N N 
35 dsRed 595 1 N N 
36 mRFP 609 1 N N 
37 dsRred 609 1 N N 
38 mRFP 618 1 N N 
39 mRFP 618 1 N N 
40 dsRed 618 1 N N 
41 dsRed 619 1 N N 
42 mRFP 633 1 N N 
43 dsRed 633 1 N N 
44 mRFP 636 1 N N 
45 dsRed 636 1 N N 
46 mRFP 645 1 N N 
47 dsRed 645 1 N N 
48 mRFP 660 1 Y Y 
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5.7.1 continued     
49 mRFP 664 1 Y Y 
50 mRFP 666 1 Y Y 
51 mRFP 171, 186, 247, 282 4 N Y 
52 mRFP 171, 306 2 N Y 
53 mRFP 186, 204 2 Y Y 
54 mRFP 186, 204, 300, 348 4 Y Y 
55 mRFP 186, 204, 456 3 N Y 
56 mRFP 186, 204, 589, 633 4 N N 
57 mRFP 186, 219, 618 3 N N 
58 mRFP 186, 259 2 N Y 
59 mRFP 186, 428, 447 3 Y Y 
60 mRFP 189, 223, 618 3 N N 
61 mRFP 204, 219 2 Y Y 
62 mRFP 204, 223, 252, 259 4 Y Y 
63 mRFP 204, 247 2 Y Y 
64 mRFP 204, 300 2 N Y 
65 mRFP 204, 414, 456 3 Y Y 
66 mRFP 228, 277, 348 3 Y Y 
67 mRFP 300, 337, 609, 637 4 Y Y 
68 mRFP 306, 321 2 Y Y 
69 mRFP 306, 321, 456 3 N Y 
70 dsRed 321, 334 2 Y Y 
71 mRFP 333, 363, 589, 618 4 N N 
72 dsRed 39, 186, 321 3 N Y 
73 dsRed 40, 348, 468 3 Y Y 
74 mRFP 444, 609 2 N N 
75 mRFP 45, 186, 609, 633 4 Y Y 
76 mRFP 589, 633 2 N N 
77 mRFP 594, 618 2 Y Y 
78 mRFP 6, 21, 39 3 Y Y 
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5.7.1 continued     
79 mRFP 6, 248, 300 3 Y Y 
80 mRFP 609, 633 2 Y Y 
81 dsRed 79, 300, 337 3 N Y 
82 dsRed 84, 240, 258 3 N Y 





5.8.1 Boolean Learning 
 Boolean functions (22) are a standard representational tool for computer and 
engineering applications. Given a set of examples in Boolean form (0's and 1's), which 
are classified as either positive or negative, a Boolean learning algorithm can establish a 
set of rules or Boolean expressions, which classify all the examples correctly. The 
approach to finding interacting positions is to train a classification algorithm to 
distinguish between sequences that are active and inactive. The resulting classification 
scheme is then examined to reverse engineer the interacting positions. Dubey et al. (21) 
showed that interacting residues can be identified from the sequences of both active and 
inactive variants obtained by recombining two or more parents by expressing the problem 
in the form of Boolean learning. Boolean learning is a classification problem where a 
Boolean function is identified from a given set of positive and negative data (22). The 
data is also in the form Boolean vectors where each dimension of the vector can have a 
value of 0 or 1. The identified Boolean function is selected because it can classify the 
given examples correctly into positive or negative. A Boolean expression or function is 
combination of binary variables joined by logical operators like `AND' or `OR'. These 
expressions can also be viewed as logical rules that can classify examples into two 
classes -- positive and negative, based on whether the rules are satisfied or not. If the 
boolean function is chosen such that it reflects the interaction between different amino 
acid residues then those amino acids can be identified. 
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 The variant sequences used by Dubey et al. (21) were obtained by the 
recombination (4,39) of two or more parent proteins. Thus, any amino acid in a variant 
sequence can be traced back to one of the parents. This limits the number of amino acids, 
which can occur in any position of the variant sequences to the number of parents. To 
formulate a Boolean learning problem, the sequence of each variant, denoted by x, was 
transformed to yield a Boolean vector X. For k parents, since each position can have up to 
k amino acid residues, a vector X =[ ]kAAA ...,, 21  can be formed where each Ai is a 
Boolean vector [ ]inii aaa ,...2,1  for an enzyme of length n. If aij = 1 (or aij is true), the 
amino acid in position j of the sequence alignment comes from the parent i and if it does 
not, aij= 0 (or ija is true). There is a small, but finite, probability that the amino acid in a 
position does not come from either of the parent (if the crossover is made between the 
codon that is not conserved); in that case, ija  is true for all i's. Note that if insertions or 
deletions exist in any parent, they can be treated as an amino acid belonging to that 
particular parent. For example, if a variant shows an insertion in position i, which is also 
present in parent j, then ija is true. 
 The Boolean function, which represents binary interactions between different 
amino acids in the sequence, was formulated by Dubey et al. (21) in the form of a 
Conjunctive Normal Form (CNF) (22). For two parents, this function can be written as: 




)( =      (A.1) 
 where  stands for `AND' and  stands for `OR'. l and m are a pair of interacting 
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positions and  is the set of all interacting pairs. Each 21 aa is referred to as a clause 
and any )(1 i
N
i=  stands for N...21 for clauses 1 through N . If f(X) is true 
(f(X) =1), the sequence X is functional. Note that due to the 'AND' sign between the 
different clauses, all of them need to be true for f(X) to be equal to 1. A clause being true 
implies that the condition given by that clause is satisfied for any sequence. For example, 
in Equation (A.1) if a1l is true a1l =1, then the clause  is true since, only one of a1l or a2m  
need to be true, due to the 'OR' sign between them. However, since a2l has to be false 
(only one of a1l or a2l can be true because the amino acid in position l can come from 
either parent 1 or parent 2), the term a1m needs to be true for the second clause and thus, 
the function to be true. This implies that both the positions l and m in the alignment need 
to have the amino acids corresponding to parent 1. Similarly, the two clauses will be true 
if both the amino acids correspond to parent 2. Thus, these clauses represent the 
interaction between the two positions. This function can also be extended to more than 
two parents(21). Boolean learning was used to find the set , which consists of the 
interacting positions. The One Clause At a Time (OCAT) algorithm (24) for a CNF 
function, shown in Figure 5.10, was used for Boolean learning to identify the function in 
equation (A.1) from the given sequences. The data set is divided into positive sequences, 
POS, and negative sequences, NEG. Step 2 of the algorithm finds a clause, which 
accepts, or is true, for all the positive examples and is not true for the maximum number 
of the negative examples. This is in agreement with any clause in a CNF function as 
described earlier, since it should be true for every positive example. By selecting the 
clause, which is rejects the largest number of negative examples, OCAT selects the most 
important clause first. It should be noted that any clause in a CNF function can be true for 
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some negative examples, but together, all the clauses in a CNF function must reject all 
the negative examples. Dubey et al. (21) modified the algorithm to search only for 
clauses of the form shown in Equation (A.1). The found clauses indicate an interaction 
between the amino acid positions involved in. 
 
Figure 5.10 OCAT algorithm. 
5.8.2 The BLSVM algorithm 
 Dubey et al. (21) also introduced the BLSVM algorithm, which combines 
Boolean learning with SVMs, a class of non-linear classification algorithms. Thus, given 
a data set consisting of points in the form of vectors, divided into two classes, they can 
find a classifying function. This function can then be used to classify any data points, for 
which the class is unknown. SVMs are based on Statistical Learning Theory and as such, 
they also try to minimize the structural risk of the solution (25,58). Data, divided into 
two different classes, are mapped into a higher dimensional feature space, using a kernel. 
The feature space is formulated in such a way that the data are linearly separable and 
linear regression can be used to find a classifying function. This function can be used to 
predict the class for unclassified data. SVMs have been widely applied in the field of 
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pattern recognition, for example, facial recognition (27,30). They have also been used for 
the secondary structure prediction of proteins (28,29) 
 The input data for SVMs are in the form of vectors x with outputs [ ]1,1y  
depending on whether the datum belongs to the positive or negative class. As mentioned 
earlier, the input data is transformed into a feature space, which is usually a higher-
dimensional space than the input space. Each vector is transformed into the feature space 
to yield a feature vector, (x), for a transformation . SVMs bypass the intricate task of 
explicitly defining a feature space for a problem by using a kernel function as the inner 
product of feature vectors: 
( ) ( )2121 ),( xxxxK =      (A.2) 
If ( ) ( )( )ll yxyxS ,,....,,, 11=  is the training data set for an SVM, the learning algorithm 







),(sgn)(       (A.3) 
 If f(x)  is positive, the point x belong to the class with y = 1 and vice versa. The 
variables  = ( 1,…, l)  are called the Lagrangian multipliers and b is called the bias. 
These variables are obtained by minimizing the risk in classifying the data. Using the 
duality theorem, minimum risk translates into the following optimization problem: 














   (A.4) 
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,0    Ci0 ,   i = 1,…, l 
 This formulation corresponds to the 1-Norm soft margin classification (58). The 
bias, b is chosen so that yif(xi) =1for any i with Ci0 .  
Since the feature vector is never explicitly used in this formulation, a function that 
can be defined as the kernel is sufficient to define the feature space. For a function to 
qualify as a kernel, it should satisfy the properties of an inner product in any space, 
symmetry and the Cauchy-Schwarz inequality ( )( )),(),(),( 2 zzKxxKzxK . In addition, 






= , should also be 
positive semi-definite (have non-negative eigenvalues) (26). Different forms of functions, 
which satisfy these properties, have been used for various problems. The polynomial 
kernel, mzxzxK )1(),( +=  and the radial basis kernel, ( )22 /exp zx  are 
frequently applied. 
 Since SVMs are based on structural risk, the classification function found by them 
has is supposed to have a better chance of performing well for data points, which were 
not included in the given data set, or in other words, have better generalization. This also 
enables them to tolerate errors in the data set. On the contrary, the OCAT algorithm for 
Boolean learning, mentioned earlier, is based only on the empirical risk, since it finds a 
function, which classifies all the given data points correctly, or in other words, minimizes 
the empirical error. Therefore, Dubey et al.(21) formulated the BLSVM algorithm by 
combining Boolean learning and SVMs. This was done using the Lagrangian variables, 
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denoted by  in Equation (A.3). These variables also can be inferred as the significance 
of the corresponding data point in the classification function. In BLSVM, this concept of 
assigning significance or weights to each data point was borrowed from SVMs and 
incorporated in Boolean learning. Thus, the same data set was used by both SVMs as 
well as for the OCAT algorithm as described earlier. However, the value of  's obtained 
from SVMs were used to evaluate the weights, W, for Boolean learning as given by 
Dubey et al. (21): 
    )max(/1)( iixW +=      (A.5) 
Where  is a weighting parameter, which can be used to vary the importance of . The 
OCAT algorithm was modified to accept these weights for each data point (21). Instead 
of using the number of examples as the criteria for selecting a clause in Figure 8, the sum 
of the weights for each example was taken into account. The weighing parameter, , 









EXPANDING THE SUBSTRATE SPECIFICITY OF PENICILLIN G 
ACYLASE 
6.1 Introduction 
6.1.1 Increasing resistance threat and the need for development of better biocatalyst 
for antibiotics synthesis 
 The development of resistance of bacteria towards antibiotics is a major economic 
and health threat. Antibiotic resistance has a huge economic impact worldwide. In the US 
alone, the economic impact of antibiotic resistance annually was five billion dollars. Two 
million cases of infectious diseases occur annually in the US which result in 90, 000 
deaths. Of these, 70% of infections that result in deaths are resistant to at least one 
antibiotic (1). Bacterial resistance towards conventional antibiotics has also been 
developing rapidly as more organisms such as S. pneumoniae, N. gonorrhoeae and 
Salmonella sp. have developed resistance towards conventional antibiotics. In addition to 
those problems, the time span for development of resistance is also short, it typically 
varies from three to fifteen years (2) which means that antibiotics quickly become 
useless. The above factors inspire the need to rapidly develop new antibiotics and new 
enzymes that produce them. 
6.1.2 Penicillin G Acylase (PGA): An important biocatalyst 
 The penicillin G acylase (PGA) protein is an industrially important biocatalyst 
used for the production of semi-synthetic -lactam antibiotics. PGA is used industrially 
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for the hydrolysis of penicillin G to produce an important intermediate, 6-amino-
penicillanic (6-APA), and phenylacetic acid. PGA also is used to catalyze the synthesis of 
semisynthetic -lactam derivatives ampicillin and amoxicillin using phenylglycine or 
hydroxylphenylglycine ethyl ester with 6-APA, respectively (3,4). Currently, PGA is 
only active towards penicillin G, ampicillin and amoxicillin  
Figure 6.1 and Figure 6.2). A PGA with altered substrate specificity towards -lactam 
resistant antibiotics such as oxacillin, cloxacillin and nafcillin would be highly desirable 
as no biocatalysts are available for these substrates currently. 
Hydrolysis 
 
   
           PenG                      PAA                                6 APA 
Synthesis 
         Amp 
                                      
 
 
 Phenylglycine ester              6 APA 
 
Abbreviations 
PAA:Phenyl acetic acid,6-APA: 6 amino-penicillanic acid, PenG: Penicillin G, Amp: Ampicillin 












































             
Figure 6.2  -lactam ring and various antibiotics. 
 
6.1.3 Characteristics of PGA 
 PGA (EC 3.5.1.11) from E. coli (ATCC 11105) is a 86 kDa heterodimeric 
amidase that undergoes complex maturation pathways. After the PGA messenger 
ribonucleic acid is translated to a polypeptide, it exists as a precursor form called 
PreProPGA that consists of a signal, connecting peptide, -subunit and -subunit (Figure 
6.3). The precursor is exported to the periplasm where it finally undergoes intramolecular 
proteolysis to form the mature PGA enzyme (5,6). Numerous studies have been 
performed on optimizing the expression of PGA and suggest that the complex maturation 
pathway necessitates a low-temperature (16°C) incubation to produce functional PGA as 
high-temperature overexpression (>30°C) frequently produces inclusion bodies in the 











Figure 6.3  Maturation pathway of PGA enzyme. S: Signal peptide (light blue), A: -
chain (blue), C: Linker (orange) and B: -chain (red). 
 
 PGA comes from the family of N-terminal-nucleophile hydrolases that consist of 
an N-terminal nucleophile (in this case, -Serine1) acting as the catalytic residue within  
a four-layer  +  structure with two anti-parallel  sheets that is known as the Ntn fold 
(Figure 6.4). The catalysis involves the stabilization of the tetrahedral intermediate by 
Gln B23, Asn B241 and Arg B69 (11) which is then followed by the release of 6-APA. 
Subsequently, the nucleophilic substrate attacks the alkyl carbonyl group attached to S1 















Figure 6.4   Crystal structure of PGA enzyme. Purple chain represent chain A, chain B is 
represented by other colors. The catalytic residues are shown with their VDW radius as 














































Figure 6.5   Proposed mechanism of PGA catalyzed reaction. The nucleophilic serine 
attacks the carbonyl carbon of the peptide bond. The oxyanion is stabilized by N241 and 
A69. The products are then released following collapse of the tetrahedral intermediate. 
R
1
 is a phenylacetic acid derivative whereas R
2
 may vary. 
 
 
6.1.4 Prior protein engineering work on PGA 
6.1.4.1 Sequence-activity relationships of PGA 
 Significant protein engineering work has been done on PGA by Alkema, McVey 
and Duggleby. Alkema and Janssen have crystallized PGA and investigated the functions 
of various residues which are tabulated in Appendix 6A (12-14). McVey crystallized 
mutant and wild-type PGA with penicillin G substrate and penicillin G sulfoxide inhibitor 
to investigate functions of various PGA residues (11). Duggleby postulated a possible 
mechanism of how PGA catalyzes the amidase reaction which is described Figure 6.5 
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(15). All these pioneers provided mechanistic insight, crystal structure and residue 
information on PGA. Efforts by research groups have also been focused on rational 
design and the optimization of the production of PGA or of the products of the reaction 
(16,17). Alkema and Janssen have mutated the residues listed in Appendix 6A because 
they believed that these residues should affect either the binding, catalysis or substrate 
specificity based on mechanistic insight obtained from three-dimensional crystal structure 
data (11-13, 15). 
6.1.4.2 Improving synthesis-to-hydrolysis ratio of PGA 
 PGA genes were shuffled to improve its synthesis-to-hydrolysis properties 
(Figure 6.6). Zhou et al. evolved PGA via DNA shuffling on PGA genes with an identity 
of 62.5% to 96.9% from Escherichia coli, Kluyvera cryocrescens and Providencia 
rettgeri (18). Zhou et al. selected for higher synthesis-to-hydrolysis activity and managed 
to obtain a mutant with 40% higher synthetic activity than the wild-type PGA gene. Jager 
et al. shuffled PGA from E. coli, Kluyvera cryocrescens and Providencia rettgeri and 
obtained 40-90% increase in the relative rate of acylation of the -lactam nucleus during 
ampicillin synthesis (19). Jager et al. used a selection prescreen on leucine auxotrophic 
HB101 cells plated on minimal media supplemented with N-phenyl-acetyl-L-leucine. The 
active PGAs liberate sufficient leucine required for growth. The selected variants were 
then screened using HPLC. 
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Figure 6.6   Kinetically controlled synthesis of ampicillin. Penicillin G acylase (PGA) can 
couple the activated side-chain phenylglycine amide to 6-amino-penicillanic acid (6-
APA). Both the activated side chain and the formed product, ampicillin can also 
hydrolyzed to phenylglycine (PG) and 6-APA using PGA as a catalyst. The synthesis-to-
hydrolysis ratio can be calculated by dividing the initial rate of formation ampicillin by 
the rate of formation of hydrolyzed products (PG in this case). Figure adapted from ref 
(19). 
6.1.4.3 Thermo-stability improved PGA variants 
 Polizzi et al. improved the kinetic thermostability of PGA (20). They applied a 
data-driven, structure-guided consensus approach to select residues potentially important 
for stability of PGA and avoided mutating the active site of PGA to decrease the risk of 
affecting its activity. Of 21 point-mutants created, 46% of PGA variants were found to be 
more thermostable than wild-type PGA. Two PGA variants had an almost threefold 
longer half-life at 50°C. 
6.1.5 Residues important for substrate specificity of PGA 
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 PGA enzyme hydrolyzes a variety of substrates. Documented substrates include 
6-nitro-phenylacetamido-benzoic acid, R-phenylglycine amide, R-phenylglycine methyl 
ester, p-hydroxy-R-phenylglycne amide and 6-nitro-3-R-phenylglycine methyl ester 
Kasche et al. investigated the substrate specificity on PGA from E. coli, A. faecalis, K. 
cryocrescens, A. viscosus and found that the substrate specificity (kcat/KM) for these 




 (21).  
 A number of publications on PGA point out that the residues that are responsible 
for substrate specificity are in the active sites of PGA (22). Residues that bind to the 
lactam ring moiety include F146 and F71 through van der Waals interactions of the 
side chains and by hydrogen bonds between the guanidium group of R145. In the acyl 
binding site, A69 and S1 interact with the phenylacetyl group. The entrance to this site 
is formed by F71 and F24. 
 Analysis of the crystal structure of PGA (PDB ID: 1gm7) indicates a relatively 
small binding pocket (Figure 6.7). This suggests that there could be a potential pocket 
binding problem if we want to evolve PGA towards a larger substrate such as oxacillin, 
cloxacillin of nafcillin using random mutagenesis. Morley and Kazlaukas (23) analyzed 
the effect of mutating residues near the catalytic sites on activity for -glucosidase, 
dioxygenase, desaturase, glutaryl acylase and subtilisin. They concluded that site-directed 
mutagenesis on regions near the active sites (5 – 10 Å) would probably be more useful 
than random mutagenesis to change the substrate specificities of enzymes as change in 
activation free energy for enantioselectivity was most significant in that region of 
proteins (See Figure 2.4). In light of the above, one can conclude that structure-guided 
approach involving site-saturated mutagenesis close to the active site to evolve PGA 
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towards altered substrate specificity would have a better chance of success than random 
mutagenesis-based methods.  
 
 
Figure 6.7   Crystal structure of PGA complexed with Pencillin G Sulfoxide. Red: 
Penicillin G Sulfoxide, Blue: Oxacillin. The amino acids a145, b 146 and b24 (Green), 
must be modified to accommodate the larger side chain.   
 
6.1.6 PGA assays 
6.1.6.1 PDAB  Schiff base chromogenic assay 
 The PDAB assay has been used by a number of groups to screen and characterize 
PGA related activities. For example, Gabriel et al. used a PDAB filter lift assay to screen 
for PGA variants with improved activity at alkaline pH (24). Two key advantages of the 
PDAB assay are that it can be used in a high-throughput fashion and it can detect 
hydrolysis of any -lactam antibiotics as it detects presence of 6-APA. The disadvantage 






        PDAB    6-APA   Schiff base chromogenic compound 
Figure 6.8   PDAB (p-dimethylamino-benzaldehyde) reacts with 6-APA to form a Schiff 
base that can be monitored at 415 nm. 
 
6.1.6.2 NIPAB chromogenic assay 
 NIPAB (2-nitro-5- [(phenylacetyl)amino]benzoic acid, (Figure 6.9) frequently 
serves as an assay for PGA.  PGA catalyzes the hydrolysis of NIPAB and this results in 
the cleavage of the amide bond, releasing a chromogenic product which results in an 
increase in absorbance at 405 nm (12,25). However, NIPAB cannot be used for screening 





Figure 6.9   NIPAB chemical structure 
 










 The cresol red and phenol red assay is a convenient colorimetric assay that can be 
used to measure penicillin G hydrolysis. Simons et al. successfully used phenol red assay 
on PGA catalyzed reactions (26). The pH change is induced when phenyl-acetic acid is 
liberated due to the hydrolysis of penicillin G. This results in a colorimetric change of the 
pH indicator. This assay is not applicable to assay all -lactam antibiotics as the side-
chains of the group linked to 6-APA have to be sufficiently acidic or alkaline to induce a 
colorimetric change. This assay could be used in a high-throughput fashion.  
 
a)  b)  
Figure 6.10   (a) Cresol red structure, (b) Phenol red structure 
 
 
6.1.6.3 HPLC assay 
 The products of PGA catalyzed reactions can be characterized by HPLC as long 
as there are appropriate standards available. HPLC has been used to analyze active PGA 
variants. Usually, C18 columns are used in connection with a pump and a UV detector set 
at 214 nm (19). The key disadvantage of using HPLC to analyze the reactions is its low 
throughput. 
6.1.7 Scope of work 
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 Protein engineering by structure-guided method on PGA was performed to 
expand the substrate repertoire. We decided to engineer PGA for activity towards 
oxacillin first, then check the variant for activity on nafcillin and cloxacillin. To start 
with, we examined the crystal structure of penicillin G complexed with penicillin G 
sulfoxide and found residues 145, 146, and 24 of PGA to be potential targets for 
mutagenesis. We then produced libraries by the overlap extension method and screened 
the library using p-dimethyl-amino benzaldehyde (PDAB) assays. 
6.2 Materials & Methods 
6.2.1 Materials 
 Most molecular biology enzymes were bought from New England Biolabs 
(Beverly, MA). The Pfu and Taq polymerase were purchased from Stratagene (La, Jolla, 
California). Chloroamphenicol was purchased from Sigma (St. Louis, Missouri). The 
inducer, isopropyl- -D-thiogalactoside (IPTG) was purchased from EMD Biosciences 
(San Diego, CA). All oligonucleotides were ordered from MWG-BIOTECH (High Point, 
North Carolina). Penicillin G Acylase genes from E. coli (PEC) and K. cryocrescens 
(PKC) were gratefully obtained from Dr. Dick Janssen (University of Groningen, 
Groningen, Netherlands).  
6.2.2 Expression and purification of Penicillin G Acylase 
 Freshly transformed colonies on choramphenicol LB selection plates containing 
the PGA gene were picked and grown overnight in LB CM, 37°C using a shaking 
incubator. 1:200 dilutions of the overnight cultures in 25 ml of LB CM at 37°C follows. 
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The cultures were grown till the OD600 reached 0.8 and IPTG is then added to a final 
concentration of 0.1mM to induce expression. The cultures were then allowed to express 
at 24°C at least 16 hours. After 16 hours, the cultures were pelleted by centrifugation and 
lysed by osmotic shock following the protocol described in ref (12). Briefly, the pellets 
were resuspended in 1/10 volume of ice-cold osmotic shock buffer (20% sucrose, 100 
mM Tris-HCl, pH 8.0, 10 mM EDTA). Follow centrifugation, the pellet was again 
resuspended in 1/10 ice-cold osmotic shock buffer (1 mM EDTA) and centrifuged again. 
The final supernatant solution contains the PGA enzymes thereafter. 
6.2.3 Library generation using overlap extension 
 The penicillin G acylase library was generated using overlap extension method 
described in (27). Degenerate primers containing NNK were ordered from MWG (High 
point, North Carolina). Primer sequences can be found in the supplement section. All 
PCR reactions were performed using Pfu polymerase and mixed following the vendor’s 
instruction (final concentrations of 0.2 mM dNTP, 1 X Pfu buffer, 0.3 pmol/ μL primers 
and ~30 ng PEC WT plasmid templates to 50 μl final volume) and cycled using the 
following program: 95°C for 2 min, hold 95°C add enzyme, 30 X (95°C for 1min, 50°C 
for 1 min, 72°C for 1 – 3 min depending on length of fragments), 72°C for 10 min, hold 
4°C. Fragments containing the NNK codons were then gel purified and used for the 
secondary reassembly PCR. For the secondary PCR, the full-length degenerate genes 
were assembled using equimolar concentrations of NNK fragments together with 1 X Pfu 
buffer and 0.2 mM dNTP. The PCR cycling protocols were: 95°C for 2 min, hold 95°C 
add enzyme, 30 X (95°C for 1min, 47°C for 1 min, 72°C for 5 min), 72°C for 10 min, 
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hold 4°C. For the tertiary PCR, ten to twenty μl of the assembly PCR mixtures were 
mixed with the end-primers (0.3 pmol/ ul final concentrations of PECfor68 and 
PECrev68) containing appropriate restriction sites. The cycling parameters were: 95°C 
for 2 min, hold 95°C add enzyme, 15 X (95°C for 1 min, 55°C for 1 min, 72°C for 5 
min), 72°C for 10 min, hold 4°C. For the tertiary PCR, it is important not to have too 
many cycles of amplification to reduce the bias of the library. 
 The insert library was digested using NdeI and HindIII enzymes and ligated into 
digested and dephosphorylated PEC vectors. The library was transformed into E. coli 
HB101 strain and plated on CM selective LB agar plates. Similarly digested and 
dephosphorylated PEC plasmids were used as control to monitor intramolecular ligation 
background. Typically, we found less than 0.5 % background. At least four of the 
transformants were sent for sequencing to confirm that we have obtained a diverse 
library. 
6.2.4 Assay of PGA using colormetric means 
 We followed the procedures described in (26).  The assay reagent mixture 
consisted of 100 mM NaH2PO4 pH 8.2, 15 mM penicillin G, 0.002% (w/v) Phenol Red in 
1 ml assay volume. Standard curves were made with various concentrations of 
phenylacetic acid. Typically, 10 ul of purified enzyme mixture was added to 1 ml of 
assay solution. The Beckmann Coulter DU 800 spectrophotometer (Fullerton, CA) was 
used to record the readings at absorbance 430 nm.  
6.2.5 Assay of PGA using PDAB solution in 96-well plates (End point method) 
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 Para-dimethyl-benzaldehyde solution (PDAB) was used to measure the amount of 
-lactam produced by the hydrolysis reaction of -lactam-based antibiotics such as 
penicillin G, ampicillin, oxacillin and methicillin. The reaction of PDAB with the -
lactam moiety forms a Schiff base which can be monitored at 415 nm. Typically, a 
yellow-colored solution can be observed in the presence of -lactam. PDAB assay is 
however, an end-point measurement method as the Schiff base reaction requires a low pH 
to occur. 
 15mM of antibiotics were mixed with ~ 30 μg of purified enzyme. The reaction is 
allowed to proceed at 30°C for at least  hour. Following that, 20 μl of reaction mixture 
was transferred to 180 μl PDAB assay solution in transparent Falcon 96-well plates. 
After 5 mins incubation at room temperature, absorbance readings were taken using the 
Fluorstar Galaxy spectrophotometer (Durham, NC). 
6.2.6 High-through put screening using PDAB filter lift assay 
 A modified procedure obtained from (24) was used. Freshly transformed HB101 
bacterial colonies were lifted using filter papers and the corners were marked with a black 
ballpoint pen so that we can map the colonies of interest back their original position on 
the plates. The colonies were lysed using chloroform vapor for  hour and then rinsed 3 
times with the freshly made antibiotic solution (2wt % in PBS pH 7.8). The filter papers 
were incubated in a sealed container to prevent excessive evaporation at 37°C for  hour. 
Finally, they were then rinsed three times with PDAB solution (7.5 mL of 3.5 wt% 
PDAB in methanol, 40 mL 40% glacial acetic acid and 20 mL of 0.05M NaOH, final pH 
of solution is 2.65, final volume is 67.5 mL). A number of labs have used final 
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concentrations of PDAB ranging from 0.0625 to 0.3% (28-31). Generally, increasing the 
concentration of PDAB increases the response as well as background. Yellow spots on 
the filter paper indicate production of -lactam and implied hydrolysis of target 
antibiotic. 
6.2.7 HPLC assay of reaction mixture 
 10X dilution of enzymes (~250 μg/ml) was added to a solution of antibiotics 
(15mM of either penicillin G or oxacillin in PBS buffer pH 7.8) and reacted for at least  
hr at 30°C. The reaction was then diluted 10X into a solution of 5mM phosphate (pH 3) 
aqueous mixture of 30% acetonitrile (5mM Phos pH 3) ~10 μL of the solution was ran 
through a Beckman Coulter System Gold
® 
reverse phase HPLC (Fullerton, CA) with a 
C18 column and 168 Detector. Elution was done using a solution containing 340 mg/l 
SDS, 5mM phosphate, 30% acetonitrile, adjusted to pH 3.0 with phosphoric acid.  
Flowrate was set at 1 ml/min. Retention time for 6-APA, oxacillin and penicillin G are 
4.12 min, 15.00 min and 9.58 min, respectively. 
6.3 Results 
6.3.1 Purification and activity assay on PGA from E .coli and K. cryocrescens 
 PGA from E. coli (pEC plasmid) and K. cryocrescens (pKC plasmid) were 
expressed in HB101 cells and purified using the osmotic shock method as described in 
the Materials & Methods section. Figure 6.11 shows that that we obtained the expected 
two main protein bands from the osmotic shock of pEC and pKC recombinant cells. The 
heterodimeric PGA protein for E. coli and K. cryocrescens consists of an -subunit ~21 
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kDa and a - subunit ~65 kDa. Colorimetric assays revealed that the pEC and pKC 
recombinant proteins show activity on ampicillin (4.04, 3.55 μmol/(mg•min) 
respectively), penicillin G (15.1, 19.9 μmol/(mg•min) respectively) but not on oxacillin, 
nafcillin and cloxacillin (<0.1 μmol/(mg•min) ). 
                   
Figure 6.11   Protein gel picture of PGA expressed. (1) Ladder, (2) Periplasmic 
supernatant for pEC, (3) Dialyzed fraction, (4) Ladder, (5) Perisplasmic supernatant for 
pEC, (6) Perisplasmic supernatant for pKC. Expected size of pEC consisted of main unit 
65kDa and subunit 21kDA. At least 90% purity of PGA were obtained for both pKC and 
pEC purification. ~2% of total cell protein production was PGA. 
 
6.3.2 Library generation using overlap extension 
 Following the characterization of the PGA genes, we used generated a library via 
overlap extension using pEC gene as a template. Figure 6.12 show that the primary, 
secondary and tertiary PCR steps for the library creation. The library was digested and 
ligated to a digested and dephosphorylated PEC vector as described in the Materials and 
Methods section. Table 6.1 lists the results of sequencing of four randomly picked 
transformants. It can be observed that we did not see any bias of DNA and amino acids 






4     5    6 
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for the four sequences. This provided evidence that that a diverse and unbiased library 
was generated.  
 
     1     2     3      4                 5        6      7       8     9    10    11 
            
Figure 6. 12   DNA gel of primary, secondary and tertiary PCR for generating library. 
Expected gene size is approximately 2100 bp. (1) & (5) 0.05 – 10 kbp Ladder, (2) 
Fragment 1, (3) Fragment 2, (4) Fragment 3, (6) & (7) reassembly overlap PCR, (8) – 
(11) Secondary amplifications on (6) and (7).  
 
Table 6. 1 Sequencing results of 4 randomly picked pEC variants. 
Residues 24 145 146
Library
Original Sequence TTT (F) CGG ( R) TTC (F)
Sequence 1 CTG (L) TTT (F) TAT (Y)
Sequence 2 CCG (P) TTG (L) TAT (Y)
Sequence 3 ACG (T) CTT (L) ATG (M)
Sequence 4 AAT (N) CCT (P) ACG (T)
 
 
6.3.3. Validation/Development of PDAB filter lift assay for screening hydrolysis of 
oxacillin and penicillin V  
6.3.3.1 96-well plates screen 
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 We confirmed the linearity of absorbance at 405nm with increasing 
concentrations of -lactam in PDAB reaction solution. Figure 6.13 shows various 
concentrations of -lactam dissolved in PBS, pH 7.8 and mixed with PDAB solution. Of 
the two curves shown, the lower curve shows the titration curve with 100μl of PDAB 
solution (0.2 wt% final PDAB concentration in a 200 μl final reaction volume) while the 
upper curve shows the titration curve using 175μl of PDAB solution (0.35wt% final 
PDAB concentration in 200μl final reaction volume). We observe that by increasing the 
concentrations of PDAB assay solution, we can obtain a more sensitive response range as 
the slope varied by a factor of two when we increased the PDAB solution from 100 μl to 




Figure 6.13   Titration curve of 6 amino-penicillanic acid (6 APA) with different final 
concentrations of PDAB solution. All data points were done in triplicates and final 
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Figure 6.14   The effect of increasing PDAB solution on absorbance at 405nm. All data 
points were obtained in triplicates using 96-well plate Fluostar Galaxy instrumentation. 
 
 To determine the effects of PDAB solution on background absorbance, we titrated 
PDAB solution and measured its absorbance at 405 nm. Figure 6.14 shows 405 nm 
absorbance readings measured at various concentrations of PDAB solution. In general, 
the amount of background absorbance increases as we increase the concentration of 
PDAB solution.  
6.3.3.2 Checking the sensitivity of Filter lift assay  
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 The sensitivity of the filter lift assay was checked by adding various 
concentrations of -lactam solution onto filter papers and checked visually for yellow 
coloration. We tested the extent of our ability to distinguish the yellow coloration of the 
reaction of PDAB solution with -lactam on nitrocellulose and VWR filter papers. Table 
6.2 shows the results of observing yellow color by using various concentrations of 6-APA 
from 0 to 800 μM that were spotted on filter papers that were subsequently rinsed with 
0.4 wt% PDAB solution. From the experiments, we determined that we could detect 
down to 470 μM of 6-APA using the filter lift assay with nitrocellulose paper. Figure 
6.15 show an example of the filter lift assay on pEC HB101 cells on penicillin G 
substrates. 
 
Table 6.2   Observable concentrations of yellow stain by the PDAB solution reaction with 
various concentrations of -lactam on filter paper. + indicates observation of yellow stain 
while – indicates absence of yellow stain. 
 
  Paper Type 




800 3.72 +++ +++ 
400 1.86 ++ +++ 
200 0.93 + ++ 
100 0.47 +- - 
10 0.05 - - 





Figure 6.15   Filter lift paper assay on pEC expressing HB101 cells. A yellow smudge 
indicates active PGA enzyme.  
 
6.3.4 Screening of variants using oxacillin substrates and secondary assay on 
screened variants 
 30, 000 variants were generated using overlap PCR using degenerate NNK 
codons (where N represents DNA codes: A/T/C/G and K represents DNA codes: T/G) at 
positions, 24, 145 and 146, as mentioned in 6.3.2. The variants were screened using 
the PDAB filter lift method on oxacillin substrates. Eight colonies around a yellow 
smudge on the filter paper were picked, grown overnight, expressed and osmotically 
shocked to obtain purified proteins. The purified proteins were reacted overnight with 
oxacillin substrate along with negative controls. The samples were then assayed using 






Table 6.3   HPLC assay on eight screened oxacillin variants along with positive and 
negative controls. C1: PBS buffer, PGA, oxacillin, C2: PBS buffer, penicillin G + OS 
buffer, C3: PBS buffer, oxacillin, OS buffer. P4: PBS buffer, PGA, penicillin G. EP is 
negative control using purified protein from empty pEC plasmids expression. Oxa1 to 
Oxa8 are the eight screened variants. 
Sample Pen G Oxacillin
C1 - Negative Control n/a -
C2 - No Enzyme - n/a
C3 - No Enzyme n/a -
P4 - Positive Control (WT penGA) + n/a











+ indicates 6-APA, a product of hydrolysis reaction of b-lactam antibiotics was detected 
- indicates that no 6-APA was detected 
6.4 Discussion 
6.4.1 The PGA gene 
 We successfully expressed, purified and characterized PGA. We obtained a 
specific activity of 15 to 20 μmol/(mg min) for pEC protein on penicillin G within the 
expected range. The pEC protein does not have detectable activity towards cloxacillin, 
naficillin and oxacillin in agreement with the absence of reported activity towards these 
substrates. This is likely due to the presence of a large side-chain group which prevents 
the antibiotic substrate from binding the PGA enzyme, thereby preventing catalysis 
altogether. Literature values for the activity of PGA were within one order of magnitude 
penicillin to our results (26,32). 
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6.4.2 Library diversity generated by overlap extension PCR 
 Sequencing of four randomly picked variants revealed that a diverse library had 
been generated. Only four sequences were obtained to characterize the library due to 
sequencing quality issues and moreover, it is not immediately obvious, how many 
sequences were really required to characterize a library with a theoretical size of 8000 
variants. We introduced NNK mutations (N represents DNA code: A/T/C/G and K 
represents DNA code: T/G) at three positions in PGA. From Table 6.1, it is evident that 
for 24 and 145, all four sequences had a different amino acid. For 146, although two 
out of four amino acids were the same, at the DNA level, their codons were different. As 
a combined effect of the above, there were also no similar amino acids combinations for 
each of the sequences. This implies that a non-biased library was generated. 
6.4.3 PDAB filter lift assay  
 As is evident from Table 6.2, the human eye can only see a yellow coloration 
formed by the reaction of a minimum of 0.47 μM of 6-APA with PDAB substrate, 
suggesting that the variant needs at least 1% conversion (47μM 6-APA detected over 
56mM antibiotics substrate used for assay) to be screened for.  Figure 6.13 indicates that 
the PDAB assay can detect down to nM ranges of 6-APA using a spectrophotometer. Rio 
et al. used a similar assay to screen for improved variants of PGA that is more stable at 
pH 8.5. Out of screening 1500 variants, they obtained two variants that were more stable 
than wild-type PGA at a more basic pH (24). One of the variants had a twofold increase 
in the half-life of the mutant enzyme at pH 8.5 as compared to wild-type PGA. To the 
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best of our knowledge, no other group has yet evaluated the PDAB filter lift assay 
sensitivity. 
6.4.4 Results of oxacillin screen 
 No improved variants were obtained after screening 30,000 variants of PGA. We 
expect that the library was thoroughly screened for improved variants as a three-fold 
screen was done on a library of 20
3
 ~ 8000 variants. HPLC secondary assay on the 
screened variants showed no activity towards oxacillin. This suggests that we could have 
obtained false positives. Two reasons that no improved variants were obtained could be 
that the directed library is not optimal for substrate specificity change and PGA could 
potentially reach its substrate evolutionary limit or that local rearrangements are not 
going to create enough room to accommodate the bulky substrates. Unfortunately, 
though, that would mean that a combinatorial approach would be necessary because 
substantial repacking to reposition the backbone of the protein to reduce or remove steric 
hindrance to the large substrates (oxacillin, cloxacillin, naficillin) would be needed. 
While the latter is impossible to test for stringently, the former could be explored by the 
creation of another library involving different residues. The key here is selecting the right 
residues for evolving the desired improvement. Possible techniques to select additional 
residues for mutagenesis could include protein docking, data-driven techniques such as 
CASTING (33-35), ProSar (36) and application of techniques such as BLSVM (37,38) 
that is described in more detail in Chapter five of this thesis. 
6.5 Conclusion 
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 Protein engineering work was done on PGA to change its substrate specificity by 
structure-guided approach. The PGA gene from E. coli and K. cryocrescens were 
expressed, purified and characterized. Based on crystal structure analysis, we targeted 
three residues 24, 145 and 146 with site-saturation mutagenesis using NNK 
randomization. After confirming the library to be diverse through DNA sequencing, we 
screened the variants using PDAB assay. No improved variants were obtained for the 
oxacillin library suggesting that that other approaches involving choosing and selecting 
different residues for mutagenesis and the use of intermediate substrates for evolution 
might be a better strategy. Additional work done using protein docking methods and the 
application of structure-guided methods such as CASTing, possibly in combination with 
NDT libraries, and/or data-driven methods such as ProSar or BLSVM to select potential 
residues for mutations could be useful to evolve PGA variants with altered substrate 
specificity. Alternatively, other enzymes such as -amino-ester hydrolases (AEH) which 
catalyzes the hydrolysis and synthesis of esters and amides of a-amino acids, can be used 
as a biocatalyst for synthesizing oxacillin instead of PGA as the substrate pocket of AEH 
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Figure 6. 16  Fragments of PGA used to assemble PGA library. The figures are not drawn 
to scale. Red boxes represent relative degenerate regions. 














Fragment 1: PECfor68 + oxab24r2blw + pEC plasmid ~400bp 
Fragment 2: pga145-6for + oxa145146r2_blw + pEC plasmid ~400bp 
Fragment 3: pga24for + PECrev68 + pEC plasmid ~1400bp 
All fragments must be gel purified to remove pEC parental plasmid. To generate full 
length PEC library insert, use combine Fragment 1 – 3 in molar ratio. PCR to reassemble 





6.7.2 HPLC data on screened oxacillin library 
6APA 
Minutes
































































































































































































C1: PBS buffer + Oxa + PGA 
Minutes














































































































































































































































































































































































































C2: PBS Buffer + PenG+OS Buffer 
Minutes












































































































































































































































C3: PBS Buffer + Oxa+OS Buffer 
Minutes


















































































































































































































































































































P4: PBS Buffer + PenG+PGA_WT 
Minutes

















































































































































































































































EP – Empty Vector on Penicillin G 
Minutes






























































































































































































































EO_ Empty Vector on Oxacillin 
Minutes




























































































































































































































































































































































































6.7.2.1 Oxacillin variants tested on oxacillin substrates 
O1O – Oxacillin Mutant 1 on Oxacillin 
Minutes
















































































































































































































































































































































































O2O_ Oxacillin Mutant 2 on Oxacillin 
Minutes
















































































































































































































































































































































O3O_ Oxacillin Mutant 3 on Oxacillin 
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O4O_ Oxacillin Mutant 4 on Oxacillin 
Minutes



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































O7O (labeled as O7P) 
Minutes



















































































































































































































































































































































































































































































































































































































































































































































































































Overlay of small peaks for Oxa mutants on Oxacillin 
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6.7.2.2 Oxacillin library assayed on penicillin G substrates 
O1P Oxacillin Mutant 1 on Pencillin G 
Minutes
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Stacked Pen G on Penicillin G 
Minutes


























































Residue Function Source 
Arg B263 Invariant residue. Mutation leads to accumulation of a protein precursor 
form. 
(11) 
Asn B241 Implicated in the stabilization of tetrahedral intermediate. Mutation 
inactivates enzyme but does not prevent autocatalytic processing or ability 
to bind to substrates. Believed to have important role in maintaining the 
active site geometry and in productive substrate binding. Crucial for 
catalysis. 
(11) 
Ser B1 Involved in direct nucleophilic attack on the scissile amide. Cys mutation 
still allows processing but makes it prone to oxidation. Involved in 
catalystis. 





Involved in stabilization along with Asn B241 of the oxyanion hole similar 
to serine proteases. Gln B23 probably have Van der Waals interactions with 
the carbonyl oxygen of b-lactam ring. Gln B23 is usually conserved.  
(11,12,15) 
Arg A145 Sides chains move significantly when ligands bind. (Coil and helical 
conformation). Moves away from active site when binded to substrate. Side 
chain connected to carboxylate group of the ligand through H bond via 
water molecules. 
(11,12) 
Phe A146 Sides chains move significantly when ligands bind. (Coil and helical 
conformation). Moves away from active site when binded to substrate. 
Plays an important role in substrate binding. Linked via a calcium ion to Phe 
B71. 
Side chains bind to B-lactam. Van der Waals interactions with the 
thiazolidine ring of penicillin G. 
Residue affects synthesis capability of PenG. 




May affect binding due to its position in the pocket. 
Met 142 aromatic residue interact with PAA side chain. 
(11) 
Phe B71 Side chains bind to b-lactam. Van der Waals interactions with the 
thiazolidine ring of penicillin G. Phe B71 forms part of extended loop Asp 
B73, Val B75 and Asp B76 that bind to calcium ion. The calcium ion help to 
define the structure of binding pocket. 
(11,12) 
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Binds to calcium ion along with Phe B71 (11) 
 
Glu A152 End of loop with Phe A146 through which A chain makes its contribution to 
calcium coordination. 
(11) 
Ile 177 Non polar residue whose aromatic ring interacts with PAA side chain. (11) 
Phe B24 Aromatic ring interacts with PAA side chain. 
Active site pheylalanine. 
(11,13) 
Tyr B31 Residue which Phe A146 moves towards to open active site for binding 
PenG 
(12) 
Phe B57 Active site phenylalanines (13) 
   






















CONCLUSIONS AND RECOMMENDATIONS 
 
 The success of protein engineering efforts is heavily dependent on the quality of 
library or the methods to select residues for targeted mutagenesis, assuming that good 
robust screening assays are available. The quality of the library generated using gene 
recombination  technologies can potentially bias the protein sequence space being probed 
by the screening assays, thereby, leading to a suboptimal variant. The methods used for 
selection of residues for targeting mutagenesis efforts can focus the search for improved 
variants in functional protein sequence space. Hence, it can accelerate and increase 
productivity of protein engineering efforts. This work mainly i) contributes to data-driven 
protein engineering research using Boolean Learning and Support Vector Machines 
(BLSVM) to identify and preserve interacting residues and engineering a library to 
preserve interactions and ii) adds to the knowledge of how to generate more useful 
libraries with better diversity. We also investigated the importance of using a good 
strategy for protein engineering by directed evolution experiments on monomeric Red 
Fluorescent Protein (mRFP) and structure-guided protein engineering efforts on penicillin 
G acylase (PGA).  
7.1 Comparison of recombination protocols 
 There are a large number of library generation protocols that protein engineers 
can use to mutate the proteins. However, the performance of these library generation 
protocols have not been compared experimentally on the same sets of proteins of 
different homology levels. A head-to-head comparison of the sequence diversity of 
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library generation protocols serves to illuminate potential issues that can arise from 
generation of libraries. Considerations such as the amount of parental templates present 
(parental background), duplication of chimeras (chimera background), crossover 
distributions and number of unique sequences are paramount for productive and efficient 
probe of protein sequence space during screening assays. By comparing the sequence 
diversity of libraries generated from DNA shuffling and recombination PCR on 
fluorescent proteins with different homology levels, we addressed deficiencies in library 
generation protocol found in the literature. 
 One significant finding from our work on comparing the performance of 
recombination protocols is that the templates used for recombination of high homology 
proteins (high level of identity) influence the quality of the library heavily. The 
experiments in Chapter 4 showed that two-sided skew templates produced the optimal 
mRFP and DsRed recombination PCR chimera library that has more evenly distributed 
crossovers, low parental background and the highest percentage of unique chimeras.  
 Another important finding from the recombination experiments from Chapter 4 is 
that DNA shuffling and recombination PCR produces libraries that require different 
lengths of nucleotide identity level for crossovers to occur, thus producing libraries with 
different diversities. The Wilcoxon rank sum statistical test and Z-statistical test applied 
on the sequences obtained from DNA shuffling and recombination PCR suggests that the 
distributions of both libraries are different and that both protocols produced similarly 
useful libraries with one or more crossovers. Hence, to reduce bias caused by dependence 
on nucleotide identity and increase diversity, one can envisage applying DNA shuffling 
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and recombination PCR together to produce a more diversified library that accesses more 
protein sequence space. 
 Recombination PCR can shuffle genes with lower DNA identity level than DNA 
shuffling but it is not clear if such an application would result in an active protein. We 
managed to obtained chimeric sequences using recombination PCR on mRFP and GFP 
genes (nucleotide identity level of 45%). However, it remains to been validated, whether 
recombination of genes with low homology yields functional proteins. 
7.2 Data-driven protein engineering 
 Data-driven protein engineering experiments using machine learning language 
such as BLSVM to identify interacting residues applied on red fluorescent proteins 
demonstrate the utility of the algorithm for identifying interacting residues and 
potentially for improving library generation efforts. In Chapter 5, we used BLSVM to 
analyze the sequence-activity information obtained from recombination experiments on 
mRFP and DsRed proteins. We proceeded to engineer the templates prior to 
recombination and compared the fraction of active variants obtained from recombined 
engineered as well as wild-type library. We found a statistically significant improved 
percentage of the number of active variants in the engineered templates, suggesting that 
the preservation of the interactions can improve the quality of a library. 
 One interesting observation from point mutagenesis experiments in Chapter 5 is 
that interactions between residues can exist more strongly in one protein than another. It 
can be argued that the same set of interactions that exist in one protein may not exist in 
another homologous protein. We found conclusive evidence of non-linear interactions in 
DsRed proteins based on the empirical observation that the fluorescence of double point 
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mutant of DsRed is reactivated non-linearly. For mRFP however, the double point mutant 
was inactive unexpectedly. 
 The next logical extension for the data-driven protein engineering experiments is 
to look at improving industrially relevant enzymes by identifying interacting residues and 
important residues (Figure 7.1). In brief, amino acid alignments of the protein of interest 
can be performed to identify potentially important residues to be mutated, shuffled and 
obtain its sequence-activity relationship via screening assays. Following that, BLSVM 
can be used to identify interacting and important residues. A directed library consisting of 
a reduced set of amino acids can then be created and screened. Following iterations of the 
above-mentioned procedure, one should have a good chance to evolve an improved 
protein while validating the method for protein engineering use. 
 
Figure 7.1 Schematic of modified BLSVM procedure for evolving proteins. Sequence-
activity landscape picture was adapted from (1). 
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7.3 Data-driven protein engineering, 3
rd
 wave: Emerging picture of the near future 
of Protein Engineering 
 The principle problem of using combinatorial methods for protein engineering or 
directed evolution (DE), the 2
nd
 wave of protein engineering, is the impossibly huge size 
of the sequence space and generating huge libraries to partially counteract this problem. 
Recent efforts in protein engineering today strive to limit library size while increasing the 
low hit rate of directed evolution. Two elements emerged to be crucial to limit library 
size limitation: computational data handling and interpretation (such as BL/SVM) and 
superior molecular biology (NDT vs NNK randomization) combined with structure-
guided limitations of mutated amino acid residues.  
 Table 7.1 illustrates the 3
rd
 wave of protein engineering due to recent advances in 
tools and methods development for protein. In general, the steps involved for protein 
engineering can be divided into i) Finding important residues, ii) Finding interacting 
residues, iii) Improving non-targeted trait, iv) Restricting nucleotide range and v) 
Restricting amino acid sites for randomization.  
 




Step Technique(s) Tools Used by 
1.  find important 
residues 
- min. least squares                
- DNA2.0**                
 - SVM 
- ProSAR - Codexis          
- DNA2.0  
2.  find interactive 
residues 
- DNA2.0**                
 - computational 
thermodynamic stability  
- rotamer G minimization.     
- Boolean Learning and 




- DNA2.0          





Table 7.1 continued 
3.  improve non-
target-ed trait& 
(i.e. stability if 
target is 
specificity) 
- exhaustive mutagenesis  
- structure-guided 
consensus 
 - structure guided 
consensus 
 
- MSA, overlay     
- MSA, overlay 
- Genencor       
- Arnold 
4.  restrict 
nucleotide range 






5.  restrict amino 
acid sites for 
randomization  




- Codexis          
- Reetz 
 
GENEy   Gene degeneracy program developed within the Bommarius group for limiting 
the nucleotide size of the library 
 
MSA: Multiple sequence alignment, Daugherty: Patrick Daugherty, Maranas: Costas 
Maranas,  
 
* The above table was consolidated based on input from Dr. Andreas Bommarius who 
previously had a discussion about the above topic, among others, with Dr. Frances 
Arnold and Dr. Manfred Reetz. 
 
** DNA2.0 applies a range of techniques that are not published: SVMR, Lasso, Ridge, 
PLS, LSVM, LPBoostR. 
 
# Bommarius lab has used i) – iii) so far. 
 
 
7.4 Protein engineering of mRFP and PGA  
 Protein engineering efforts on mRFP and PGA did not result in improved variants 
but the insight gained from these experiments can serve to design future experiments that 
would improve the probability of success. From Chapter 3, we mentioned that a more 
red-shifted version of mRFP, mPlum, was already obtained and that two rounds of 
directed evolution was insufficient to find improved variants. However, a version of 
mRFP with a higher relative quantum yield still remains to be found. A recent successful 
work done on improving the brightness of blue fluorescent protein (BFP) point to 
potential methods to improve the relative quantum yield of mRFP.  Mena et al. created a 
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targeted synthetic library of BFPs based on considerations of distance from chromophore, 
the direction the side-chains were pointing and its involvement in catalysis of 
chromophore formation (2). The variants can be subjected to fluorescence activated cell 
sorting (FACs) to screen for the brightest fluorescent protein. Alternatively, the variants 
can be expressed on plates and screened using an imaging machine from which 
fluorescence intensity can be determined. 
7.4.1 PGA screen using penicillin V 
 One of the future directions for PGA experiments should include screening the 
library for activity towards penicillin V. From the crystal structure data presented in 
Chapter 6, it is conceivable that the current goal of evolving substrate specificity of PGA 
towards oxacillin in one step may be too demanding on the evolutionary pathway. 
Instead, a bridging or intermediate substrate, which displays less substrate hindrance than 
oxacillin, could be used as a target for evolution first. Following that, one can attempt to 
evolve PGA to be more active towards more difficult substrates such as oxacillin, 
cloxacillin and nafcillin. 
7.4.2 PGA fluorimetric screen using pH sensitive fluorescent proteins 
 The screens for PGA experiments could also be improved by using fluorescent 
proteins co-expressed with PGA enzyme in combination with FACs for screening. 
Chapter 6 showed that possible background signal issues plague the filter lift assays for 
the current PGA experiments. A high-throughput fluorimetric screen that has better 
signal-to-noise ratio for PGA assays would be extremely helpful to find improved 
variants. One possible high-throughput assay involves the use of pH sensitive fluorescent 
protein such as pHluorin or enhanced green fluorescent protein (EGFP) that changes 
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spectral characteristics when it detects a change of pH, due to PGA activity on antibiotic 
substrates that liberates an acidic moiety upon hydrolysis. Schuster et al. demonstrated 
the use pHluorin in vivo assay to screen for local hydrolytic induced pH shift in E.coli 
cells (3).   
7.4.3 Creation of a novel fluorimetry based screening system using penicillin 
receptors and fluorescent proteins 
 Another plausible assay involves the use of penicillin binding receptors such as 
BlaR1 that changes its conformation upon binding to -lactam (4). Fluorescent proteins 
positioned in the relevant loops (Figure 7.2) would move apart during the binding event, 
thus, inducing a change in fluorescent resonance energy transfer (FRET). Alternatively, 
cells that have BlaR1 signal transduction machinery can be genetically modified to 
incorporate GFP gene, either in replacement, or fused to the -lactamase gene. The cells, 
in theory, will express GFP in the presence of -lactam, thus allowing one to identify 
cells that have -lactam present fluorimetrically. Thereafter, the genetically engineered 
cell strains can be used for expressing the PGA variants and detect for activity towards -






                       
 
Figure 7.2 – A representation of the BlaR1 binding receptor from Bacillus lichiniformis.  
-lactam binds to serine residue (S
402
) and induces a conformational change that results 
in metallo-proteases cleaving loop L3. Fluorescent proteins (F1, F2) which are placed in 
loop L3, are separated. This results in FRET decreasing. Figure adapted from (4). 
 
7.4.4 Selection assays to decrease screening efforts 
 Selection assays utilizing an E. coli auxotroph combined with the relevant 
antibiotic side-chain analog can also be  used for assaying improved variants. Recent 
work by Jaeger et al. showed that the use of a prescreen selection assay when evolving 
hybrid PGA is a viable way to eliminate inactive variants (5). They used an auxotroph 
such as HB101 E. coli strain that requires leucine in combination with minimal LB plates 
and N-phenyl-acyl-L-leucine to prescreen active shuffled chimeras of PGA from E.coli, 
Kluyvera cryocrescens and Providencia rettgeri. Active PGA will liberate leucine that is 
required for growth of E.coli. Following that, secondary assays on the selected variants, 
were done using high performance reverse chromatography to verify synthesis of 
ampicillin and to obtain activity. Assuming stable and suitable analogues with the 
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targeted side-chains are accessible, we can use selection assays to reduce the number of 
variants for screening. 
7.4.5 New libraries for PGA experiments 
 Lastly, an important aspect for future PGA work is the design of new libraries 
using techniques such as protein sequence activity relationship (ProSar), BLSVM and/or 
combinatorial active-site saturation testing (CASTing) (6). Assuming that a good screen 
is accessible, one can create a targeted restricted library for PGA for evolution towards 
different antibiotic substrates. ProSar and BLSVM can identify key residues that affect 
the activity of the PGA while CASTing limits mutagenesis to residues that would likely 
be important for substrate specificity change. These smart directed libraries should in 
theory accelerate convergence towards the desired optimized variants, as the protein 
sequence search is limited to functionally relevant space. 
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